Home Blog Page 125

WHO Urges COVID-19 Vaccine Manufacturers to Uphold Pledges

0

The World Health Organisation on Thursday urged COVID-19 vaccine manufacturers to make good on their commitments as the planet’s poorest countries await their first doses.

WHO Director-General, Tedros Adhanom Ghebreyesus said the Covax facility – the global COVID-19 vaccine procurement and distribution effort ensuring poorer countries can access doses – was now ready to begin vaccine distribution.

Around 336 million AstraZeneca-Oxford doses and 1.2 million Pfizer-BioNTech doses – the only two vaccines with WHO approval – are set to start being shipped out later this month through Covax.

WHO Urges COVID-19 Vaccine Manufacturers to Uphold Pledges
WHO Urges COVID-19 Vaccine Manufacturers to Uphold Pledges

“At the beginning of the year, I issued a call to action to ensure that vaccination of health workers was underway in all countries within the first 100 days of the year,” Tedros told a news conference.

Friday “marks the half-way point, and we have made progress, but we are not there yet.

“With the emergency use listing of two versions of the AstraZeneca vaccine this week, Covax is ready to roll out vaccines and is waiting for several manufacturers to make good on their commitments,” he said, without elaborating.

On Monday, the WHO gave the seal of approval to the AstraZeneca vaccine being manufactured in plants in India and South Korea, meaning it can now be shipped out via Covax.

The facility is set to issue its final distribution list for the first wave of deliveries next week. The first doses will be delivered by the end of February, with the bulk in March.

Around 145 economies are set to receive enough doses to immunise 3.3 per cent of their collective population by mid-2021.

During his news conference, Tedros noted that countries in Europe – which have been striking their own deals with manufacturers – were aiming to vaccinate 70 per cent of their populations in a similar same time frame.

Trinidad and Tobago’s Prime Minister Keith Rowley, chairman of CARICOM, the 15-member Caribbean Community, voiced fears that small states, lacking bargaining power, would be shut out of the global vaccination drive.

“As there is the understandable rush to receive the vaccines and inoculation of our various populations, we are more than a little bit concerned that there is, or is to be, hoarding and price-gouging as well as undue preference in some quarters,” Rowley told the WHO press conference, via video-link.

“We are all yoked to an invisible destroyer. It is my hope and plea that… on this occasion, the rich take care of the poor.

“All we ask as members of the family of nations is that we not be forgotten, ignored — or worse, taken advantage of in this business of life and death.”

The WHO launched its annual Strategic Preparedness and Response Plan for 2021 on Thursday, saying $1.96 billion was needed to fund another year of battling the pandemic.

The plan’s six objectives are to suppress transmission; reduce exposure; counter misinformation; protect the vulnerable; reduce death and illness; and accelerate equitable access to vaccines, diagnostics and therapeutics

(AFP)

Developing Abundance Mindset for Optimum Performance

0

The beginning of a new year often comes with a renewed determination and commitment to be, to do, to have and to create. A new year brings fresh pages filled with new opportunities and possibilities to do things better or differently.

Achievers often set goals toward a brighter future and a better life at the start of a new journey.  How can we maximise the possibilities and opportunities inherent in each day of this year? Studies have shown that success is 80 per cent mindset and 20 percent strategy. If you are keen to advance in all areas of life despite the challenges of  COVID-19, you must transform your mindset for abundance, growth, and high performance.

Firstly, you must develop “abundance” mindset. More often than not, when people who are smart struggle in any area of life, it is because of their mindset rather than know-how. Perhaps you also know someone who is smart, kind and hardworking but yet still far behind in his or her dreams, despite great effort for years. It is because they haven’t developed abundance mindset.

80 hearty cheers to an Icon: Sir Ifeanyi Atueyi
Pharm. Sesan Kareem

Scarcity mindset is a pattern of thinking that sees opportunities, things and money as scarce resources. This mindset often manifests itself in fierce competition with others, an attitude of ingratitude and a low self-worth. On the other hand, abundance mindset is characterised by healthy competition for opportunities, open mind for new ways of doing things, an attitude of gratitude and a good self-image.

When you look carefully around you, what you will notice is abundance: people, places, things, and opportunities. Nature is a storehouse of abundance. It is always expanding and will always be. The creator of man will always make things abundantly available for him. It is now left for each individual to conquer his self-imposed limitations and develop the consciousness to participate in His abundance.

Remove any thought of scarcity from your marvellous mind. Stop allowing your physical reality shape your dominant thought. Open your subconscious mind to abundance, prosperity and success.

Secondly, you must develop a growth mindset. Having a growth mindset helps you to keep learning, improving ad becoming better as a person and in the value you create for others. A growth mindset believes in the power of information, wisdom and action. The opposite of a growth mindset is a fixed mindset – a type of thinking that sticks with old ways of doing things and fights new and better way of doing things. A person with a fixed mindset is not open to learning, relearning and unlearning.

To accelerate your progress this new year, you must be open to learning new skills and developing better habits that will serve you better. Most importantly, you must be open to unlearn old habits that not supporting your growth and progress.

A research conducted by Stanford University Psychologist, Carol Dweck, examined the mindset of young students. She found out that children who have the fixed mindset that intelligence is predetermined are unable to overcome academic challenges, compared to those who have a growth mindset, which believes that intelligence can be developed.

Researchers from the Universities of Miami and Yale also found that middle-aged adults with more positive beliefs about aging lived 7.5 years longer than their counterparts with a less positive self-perception. Simply put, your mindset can prolong your life.

Thirdly, you must develop a high-performance mindset. To record optimum achievement, this year, you must up your game, raise your standard and expect more from yourself than anyone can demand from you. Every act you do, you must do it well. You must develop a reputation for great work, excellent service and extraordinary contribution.

Whatever your hands find, do it with all your strength, heart and mind. To make this year highly profitable and productive, you must make each day highly profitable and productive. To make each day successful and rewarding, you must make each act successful and rewarding. Always remember, that it is not what you do, it is all about how you do it. It is more about how well you do your duties and less about how many tasks you have accomplished. Developing a high-performance mindset will fast track your journey towards success ad greatness.

In conclusion, you have all what it takes within you to make year 2021 productive, profitable, rewarding and memorable for you and your loved ones if you become intentional in developing your subconscious mind for abundance, prosperity, growth and optimum performance. If you want to do great things, have new things and create new realities this New Year, you must first become a new you with an abundance mindset.

 

ACTION PLAN: Develop daily habits that will help you grow, perform better and develop abundance mindset. Be conscious about of you think and how you think always.

 

AFFIRMATION: I have abundance mindset. I am blessed and highly favoured.

How to Know When COVID-19 Variant Becomes Worrisome- Experts

0
How to Know When COVID-19 Variant Becomes Worrisome- Experts
NIMR DG, Prof. Babatunde Salako (middle), flanked by some Circum Vent principal investigators in a group photograph during the workshop, held at NIMR’s out patient clinic recently.

For every mutation of the SARS-CoV-2, there may not be need to panic as new variant develops every day, but it calls for attention when the virus begins to change a patient’s dynamics, Director General, Nigeria Institute of Medical Research(NIMR) Prof. Babatunde Salako, has said.

This is even as the Public Health England recently discovered 38 British cases of a new COVID-19 strain first found in Nigeria.

The health body has marked the mutation, which has been labelled as B1.5.25, as ‘a variant under investigation’, which may be resistant to current vaccines.

 

The NIMR DG, who described severe strain as variants of concern, noted that they need to be addressed immediately whenever they are discovered.

 

Fielding questions from journalists during the Circum Vent workshop of principal investigators organised by NIMR recently, Salako stated that although a few variants may not be captured by vaccines, but most vaccines producers have planned their products around the spike protein to arrest majority of strains.

 

“Mutation happens everyday but it becomes important when it changes the dynamics of patients and cause more deaths, at such, they are called variants of concern.

 

“It is worthy of note that people have planned their vaccines around the spike protein and if they will be able to take care of any strain at all.

 

“ There is no doubt that some strains may not be treatable by some vaccines, that was why South African government first stopped the AstraZeneca vaccine because studies have shown that it wasn’t effective, but we don’t have that strain in Nigeria, so we can use the vaccine”, he quipped.

 

In the wake of the various strains of the virus in the country, the Professor of Nephrology stressed the need for health workers to protect themselves from the disease as they are more vulnerable and can easily spread it to numerous patients.

 

Salako disclosed that aside from distributing non-invasive ventilators to heads and representatives of health institutions, the event was to further observe how both patients and doctors are faring during the second wave of the virus.

“We have set up a protocol to observe how patients and health workers fare with the non-invasive ventilators.

“You will recall how we got about 140 of these ventilators and gave out 60 of them to Federal Ministry of Health, as well as eight to each teaching hospitals selected for management of severe COVID-19 cases”, he narrated.

A Consultant Oral and Maxillofacial surgeon, Prof. Wasiu Adeyemo, recommended personal responsibility as the progress path out of the disease for everyone saying government alone cannot attain it.

He urged doctors and patients to always adhere to safety protocols whether in the hospital or outside the hospital, as that is the surest protection from the infection.

“The way forward is for all of us to be responsible. Don’t forget that in the first wave, people talked about conspiracy surrounding COVID-19.

“Now, one year down the line, we are talking about the vaccines. It is important to note that it is not just down to the government alone. This is why I earlier said we need massive awareness,” he stated.

 

At 80, My Life is Dedicated to Mentorship and Charity Works – Prof. Obiorah

0
At 80, My Life is Dedicated to Mentorship and Charity Works – Prof. Obiorah
Prof. Bona A. Obiorah

In this exciting interview, eminent scholar and black Africa’s first professor of Pharmaceutical Technology, Professor Bona Anayochukwu Obiorah, who just clocked 80 years, says he is renewing his commitment to mentoring younger people and doing works of charity, adding that he would like to be remembered for his contributions to pharmacy education and research. The erudite professor, who worked as a consultant to the World Health Organisation (WHO) for many years, also reveals the dramatic events that led him to studying Pharmacy at the University of Ife (now Obafemi Awolowo University), even without applying for it as a course of study. He further shares his routines, since retirement in 1999, while advising the current generation of pharmacists to make the best of their professional calling.  Excerpts:

 

Kindly tell us a little about your background

My early education was at the University of Ife (now Obafemi Awolowo University, Ile-Ife), where I got my Diploma in Pharmacy and, later, B.Pharm. In those days, if you made a first class or 2:1 (second class upper), you would have automatic scholarship to go for a higher degree. So, I went on to the University of London, where I did my PhD in Pharmaceutical Technology. After that, I returned to the University of Ife as lecturer.

In a period of seven years, I rose to become a professor of Pharmaceutical Technology and, by that appointment in 1981, I became the first professor of Pharmaceutical Technology in the whole of black Africa. I had remained in academia, until 1999, when I retired from the University of Benin.

Since 1999, I have been involved in extensive consultancy to World Health Organisation (WHO) and other agencies like the Global Alliance for HIV/AIDS. I have published extensively in notable journals in Pharmacy and other areas.  It has been a very pleasant experience being in academia. I have worked in the hospital for a few years. I was in the hospital service when the war broke out.  It was after four years that I left hospital service.

 

By the grace of God, you will clock 80 on 21 February, heralding your entry into the league of octogenarians. How do you feel attaining 80 years of age? Are there things you would like to start, discontinue or reinforce at this time?

Thank you very much for your congratulatory message. I do appreciate it most sincerely. It is not a small thing to clock 80 years in Nigeria now. This is a country where if young people clock 40 years, they are celebrated. At 80, I am most grateful to God Almighty for this privilege and I do not have any new plans to start any new projects other than help in charity works, help in mentoring younger ones and contribute generally to the progress of Pharmacy in terms or writing and making contributions to the development of knowledge.

 

As an octogenarian, what are the lessons you have learnt in life which you would like the younger ones to pay attention to and learn from?

There are many lessons one has learnt over the years but the most important thing is that there is no competition in life. No two people are the same. You go at your own speed and one must avoid greed. Many of the things that you think that you need are really wants. God will always provide our needs but not our wants. To the younger ones, I will always advise that they work out their trajectory early enough in life, but not try to copy other people. Copying other people will not help anybody.

How would you describe your days in university service?

While I was in university service, I always advised my students that they must learn to crawl before they can walk. The problem with young people these days is that they are always in a hurry, and this has created some of the problems we have in Pharmacy.

For example, when I was at OAU and UNIBEN, students were always reluctant to go to the University College Hospital, Ibadan, because the hospital was working seven days a week and the students wouldn’t want to miss weekends. I used to tell them that if a hospital could dispense with their services on Saturday and Sunday, it could dispense with their services altogether.

My research interest in the area of Pharmaceutical Technology has always been in formulation design. That is one of the areas in which I was working with WHO, using Nigerian additives, Nigerian starches, and Nigerian corns.

Some of my students, in their graduate work, researched into some of these additives, got their PhDs and I’m happy to say that, at least, four of them that went into academia and became professors in the area of Pharmaceutics and Pharmaceutical Technology.

The founder and publisher of Pharmanews, Sir Atueyi, was my classmate, right from my year one at the university and we graduated the same year. He had a 2:1 and I had same, too.  He is known all over the world for what he is doing in pharmaceutical journalism. So, there is dignity in labour and you have your self-respect.

As an elder in the profession, I would want to harp on the issue of respectability. I will continue to harp on the issue of dignified labour.

When would you describe as the most memorable point in your career?

During my university service, I became dean of the Faculty of Pharmacy, University of Benin in 1984 and I had a second term of two years in 1986. When I finished as dean, after the four-year stint, I continued mainly with research activities. But in 1993, I was appointed through election in senate as deputy vice-chancellor, Administration, at the University of Benin. This ran from 1993 to 1995 and I was re-elected for a second term in 1995 till 1997.

It was after serving as deputy vice-chancellor, that I said I had paid my dues in the university service, after more than 30 years as an academic. It was after that, that I started serving as consultant to different organisations.

Outside academia, I was active in the Catholic Church. I became a Knight of St John (KSJ) in 1988 and I was also involved in the running of tertiary institutions. I became the chairman of the governing council of Anambra State College of Education, which was in Awka then but now relocated to Nsugbe.

What exactly informed your decision to study Pharmacy at a time when there were quite a few people one could imitate in the field?

I would say it was Providence. I applied to study Agriculture at the University of Ibadan and was admitted in 1959. However, while preparing to go to Ibadan, someone told me he saw my name under the Eastern Nigerian Government scholarship for Pharmacy.  I did not know what Pharmacy was and I did not apply to Eastern Nigerian Government for scholarship to study Pharmacy.

So, I went to the Ministry of Education in Enugu and was told that they needed students that would study Pharmacy and since I had a very solid result in the sciences, I was one of those selected by the Eastern Nigerian Government to study Pharmacy.

I went around asking what Pharmacy was from older people who had an idea of the course. In any case, I needed a scholarship to go further in my education; so I accepted the offer. That was how I found myself in Pharmacy and, in a way, I never regretted accepting that scholarship.

Even going into Pharmaceutical Technology was an act of pure providence because my interest for postgraduate work was Pharmacology but again the vice-chancellor of the University of Ife invited me to his office and said, “I will not send you to London to study Pharmacology. We are in dire need of lecturers in Pharmaceutics. So if you want to go overseas to do postgraduate work, it has to be in Pharmaceutics.”

Just coming out of the civil war at that time, it was very necessary for me to get out of Nigeria at that time for whatsoever reason. So I accepted to go for a postgraduate study in Pharmaceutics, which, in fact, was an area that in which I thought I was weakest.  Pharmacology was my strongest area.  So I went to London and worked very hard in Pharmaceutics. In fact, I was made to do the qualifying exams, I excelled and I did straight PhD; I didn’t have to do masters.

 

When you look at the current state of pharmacy practice these days, what are the areas you would like to see improved? Or are you satisfied with the current state of practice in Nigeria?

Thank you for this question. Pharmacy is a very noble profession. For one to be a real pharmacist, you must have eyes for details. When a doctor makes a mistake, he kills the patient.  When a pharmacist makes a mistake, he may kill thousands of people.

Some years back, a young pharmacist at the University of Nigeria Teaching Hospital made a mistake when he was formulating paracetamol syrup. What he did was, instead of picking propylene glycol as a solvent for the paracetamol which is very insoluble in water, he picked ethylene glycol.

The two are glycols – propylene glycol and ethylene glycol. Propylene glycol is a very safe additive but ethylene glycol is a deadly poison. He made up the bulk paracetamol syrup and, within days, children were dying like flies and it was on checking the ingredients he used, that it was discovered that he had mistakenly picked ethylene glycol, instead of propylene glycol. Before this error was discovered, several children had died.

If an architect makes a mistake in design, when people pass, they will say, “What useless architect designed this building?” And that can be corrected. But if a pharmacist makes the type of serious mistake that was made in the preparation of that paracetamol, hundreds of children can die.

In my time at the hospital, pharmacists were very highly respected. It was during my time that Pharmacy was moved from being technical grade to professional grade and if you had your B.Pharm, you would be classified as a pharmaceutical officer.

What you find these days, however, is lack of dedication. The rush to make quick money. The young pharmacist is in the hospital but his mind is outside to make quick money. The same problem is what we have in retail or community pharmacy.  Some of the young pharmacists who go into retail pharmacy do this “register and go”.  And register and go is such a dangerous thing because even the trader who is employing the young pharmacist does not stay in the shop. He goes in the evening to collect the money for the day. So, the patients are exposed to danger.

But one thing about the current hospital pharmacy practice in Nigeria is the introduction of clinical pharmacy which has moved Pharmacy from product-orientation to patient-orientation. So, the young pharmacist with the PharmD now spends time with the patient, interacting and explaining everything about the pharmaceutical product being given to the patient – and not just pushing out the drugs through the window in a small cubicle. So, hospital pharmacy is now very well advanced and will continue to advance.

 

When look back at your struggles and contributions over the years, what would like to be remembered for?

The main thing I want to be remembered for are my contributions in the areas of pharmacy education and research. I have spent a greater part of the last 40 years teaching and researching in different pharmacy schools. I would like also to be remembered for my contributions to the World Health Organisation (WHO) where I served for many years as a consultant on the establishment of small and medium pharmaceutical plants in developing countries. I am happy that many of the developing countries are applying some of the findings and recommendations in those researches and it is paying off for them.

Also, one of the things that give me the greatest pleasure is the opportunity to have been in the “factory” for the production of manpower in Pharmacy. When I attend pharmaceutical conferences, I see some of these my children and grandchildren doing well in different aspects. That gives me great pleasure. During my travels abroad – maybe I’m getting onto a train or a bus – somebody grabs my bag and says, “Sir, please let me help you.”

These are faces I can’t remember. In fact, on a few occasion, they take my address and before you know it, they are bringing a lot of gifts for me, drop in my place and disappear. Sometimes, they don’t even leave their names.

 

How do you keep busy these days?

Talking about keeping busy, the only outdoor activity I do now is walking. I keep fit by walking.  So I do a lot of walking but within my compound. I go round my compound about 10 times in the morning. That gives me about that two kilometres. Then after walking, I do a workout. This keeps me going health-wise and I am looking forward to being 80 in a few days’ time.

I really believe that since I still have good health, I will continue with my exercises. Of course, I still do a lot of reading. Reading gives me great joy. The last few months we have been in this coronavirus pandemic, I have increased my reading and I have also slightly increased my workout because the lockdown is not easy for anybody.

What Everyone Should Know About Herpes – Experts

1

What everyone don’t know and should know about herpes is that it is a common sexually transmitted infection, according to Brian A. Levine, a New York practice director for the Colorado Centre for Reproductive Medicine, many don’t understand what the herpes virus is, how people get it, and how they can protect themselves.

He explained that herpes is a virus that stays in your body once you get it, there are two types: herpes simplex 1 (HSV-1) and herpes simplex 2 (HSV-2). “Type 1 is what people think of as classic oral herpes,” Levine said the most typical symptom of HSV-1 is cold sores around the mouth. “Type 2 is the most common cause of sexually transmitted herpes, but we’re starting to see more type 1 with genital infections,” says Levine. That happens when a person who has HSV-1 in their mouth transmits the virus via oral sex.

What Everyone Should Know About Herpes - Experts
What Everyone Should Know About Herpes – Experts

A former staff and volunteer of American Sexual Health Association (ASHA), Emily Duberman gave a broad knowledge and also answered many questions from the public about STIs in her time at ASHA, including genital herpes. She shares her thoughts on how to manage this common infection.

She said herpes is not too much of infection one should be scared of, noting that it is mild skin condition that can be managed very effectively.

“It is estimated that one out of six people have genital herpes. About 90 per cent of them don’t know it. Herpes (oral & genital) cannot be spread through inanimate objects such as spoons, glasses, razors, towels, bed sheets, etc. Herpes can only be passed through direct skin-to-skin contact with the infected area such as kissing, oral sex, genital-to-genital rubbing, vaginal, and anal sex,” Durberman added.

She explained how herpes can be spread and how they can be managed:
Herpes (both oral & genital) can be spread even when there are no symptoms or sores. This is called asymptomatic shedding. Suppressive antiviral therapy significantly reduces asymptomatic shedding (and outbreaks). Valacyclovir taken daily can reduce risk of transmission to a partner by as much as 50 per cent.

Herpes is a very manageable skin condition and does not cause any damage to internal organs.

People with herpes have very normal romantic and sexual relationships. After diagnosis, you may feel like your life may never be the same again but Herpes is one of the most common viruses in the world, affecting more than 65 percent of all people aged 15 to 49 as HSV-1 and about 11 percent as HSV-2. It’s also very contagious, with most people getting it during childhood — a characteristic that’s a key part of why it’s so commonplace. When most people hear of “catching herpes,” they think of sexual activity.

But herpes doesn’t always spread through sex. From birth, to innocent, accidental physical contact, non-sexually transmitted herpes is a very real thing you should be aware of.

In this guide, she explained how herpes can be transmitted from person to person, ranging from sexual methods of HSV-2 or HSV-1 transmission to other ways you could catch (or accidentally transmit) either form of the herpes simplex virus to other people.

Sexual Contact

Before we get into non-sexual ways in which the herpes virus can spread, let’s cover the most obvious: sex.

Genital herpes, which is the form of herpes most people associate with sexual activity, is most often transmitted through sexual activity. If you have genital herpes and have sex with a person that doesn’t have the virus, there’s a significant risk of you transferring it to them.

Herpes transmission can take place even if you don’t have any symptoms of genital herpes. In fact, most people with genital herpes are asymptomatic, meaning herpes transmission can occur without the infected person being aware of their status.

Sexual contact usually spreads the HSV-2 form of the herpes virus. However, it’s also possible for HSV-1 to spread from the mouth (where it causes oral herpes) to the genitals through oral sex.

It’s even possible for herpes to spread from the mouth to the genitals without direct oral sexual contact. For example, if you have oral herpes and touch your mouth shortly before touching the genitals of your sexual partner, there’s still a risk of transmitting the virus.

While it’s not possible to completely eliminate your risk of spreading herpes through sex, there are steps you can take to reduce your transmission risk. Our guide to sex with herpes includes several tips and tactics that you can use to make sex safer if you have HSV-1 or HSV-2.

Kissing

One of the most common ways in which the herpes virus spreads is through kissing. If you have HSV-1, which usually causes oral herpes, there’s a risk of you transmitting the virus to others via your saliva.

When the herpes virus is active, it’s present in the saliva in your mouth and on your lips. Even a momentary kiss can be enough for HSV-1 transmission, resulting in them becoming infected.

Like genital herpes, it’s possible to pass on oral herpes (typically HSV-1) even if you don’t have any symptoms, through a process called “shedding”. Many people with oral herpes are completely asymptomatic, meaning the virus can spread through their saliva without them ever knowing about their herpes status.

Birth

Herpes can also spread through birth. Women who have active herpes at the time of birth (for example, an ongoing genital herpes outbreak) can potentially pass the herpes virus on to their child during the process of giving birth.

Herpes transmitted during birth is a serious health risk for infants, with the potential for infections of the skin, eyes and mouth. Many infants that develop herpes through birth also experience diseases of the central nervous system caused by the virus. In some cases, the virus can even be fatal.

For this, doctors take significant precautions for expectant mothers with active genital herpes outbreaks. Women with herpes should be advised to undergo cesarean delivery to minimise risks to their child, or examined to make sure there’s no sign of an outbreak during delivery.
Even though genital herpes is fairly common, it’s very rare for it to be transmitted to infants at delivery. Up to one in 3,200 newborn babies in the U.S. are infected with the virus during delivery, and 10 out of every 100,000 globally, making herpes acquisition through birth a rare event.

Indirect Contact

Finally, it’s also possible for herpes to spread through indirect contact between a person with the virus and an uninfected person. For example, while improbable, the herpes virus can theoretically spread from one person to another through a wet towel, straw, utensil or other shared item.

The key word here is improbable.

Literature suggests that while the herpes virus does survive for some period of time outside the human body, the most commonly known mode of transmission is through direct contact with an infected person.

However, it is hypothetically possible for herpes to spread from one person to another by quickly reusing a straw, spoon or other item that came into contact with an infected person’s saliva.

 

What are your gods?

0

In my younger years in the village, I used to think there were two categories of religious people. In the first category were the majority, mainly parents and older ones, who were heathen or pagans or idol worshippers. In their homes were some idols made of wood and iron that had been around for many years. In the other category were Christians. They were fewer in number and had basic education to enable them read and write.

Sir Pharm. Ifeanyi Atueyi

In the primary school, more of the children were from Christian families. In a large family, some were Christians while others were idol worshippers. With serious evangelistic work of the missionaries, people were being converted to Christianity, which had the Church Missionary Society (CMS) and the Roman Catholic Mission (RCM) as denominations.

Ironically, these two denominations were somehow antagonistic to each other, with each claiming superiority over the other in spiritual matters. As children, we used to taunt one another and even quarrel because of denominational   differences. However, the main division was between Christians and idol worshippers. Christians gradually adopted superior colonial cultures and education, making   our traditional cultures appear inferior.

Today, the church still contends with the problem of harbouring idol worshippers, but not in the form of those our parents and grandparents. Such people believe that there is only one God and bear the label of Christians.  But they will not give God exclusive right of way in their lives.  They are not ready to offer full or undivided allegiance to Him.  Of course, on Sundays they worship God in their churches but on weekdays God has little or no place in their lives. They have other gods or idols they worship.

My concept of idol worshipping has long changed. I do no longer have to go to the heathen to find other gods. Christians now have idols in many forms.  Whatever you love more than God is your idol. Consequently, man’s heart is full of idols. Men, women, rich and poor, educated and uneducated, are all guilty of idolatry.

Do you know that someone can make himself a god? You can make another person your god. You can make your child, parent, spouse, boss, or even spiritual leader your god.  Some take fashion as their god because their time and thoughts are mostly devoted to looking good and trendy. Food can be your god. Philippians 3:19 says, “…whose end is destruction, whose god is their belly…”

With many, their god is money but God will not accept a divided heart. Fame, work and pleasure can become gods when we concentrate too much on them for personal identity, meaning and security.  No one sets out with the intention of worshipping these things. But considering the amount of time we devote to them, they can grow into gods that ultimately control our thoughts and energies.  However, letting God hold the central place in our lives keeps these things from turning into gods.

It took me many years to realise that I was also an idol worshipper even though I was a Christian, baptised as a child. All along, I was just going through life as a nominal Christian. Of course, going to church was a habit from childhood. Undoubtedly, church is a wonderful gathering of friends and relations for social and spiritual activities. When I started the business of Pharmanews in 1979, it became obvious that one of the gods I worshipped was my work. I got so engrossed in the work that it practically took over my life.

I literally gave my life to the god of work. My thoughts were completely dominated by work. It was such that I had to start skipping church services. My god advised me that I could achieve more reading and writing on Sunday mornings when my wife and little kids might have gone to church.  Occasionally, I would be in church to meet some friends.   You can imagine my prayer life at that time.

I thank God that I was delivered from that my god at a breakfast meeting of the   Full Gospel Business Men’s Fellowship International (FGBMFI) held on Saturday, 11 February, 1989. That day was a turning point in my life. At the end of the message given by Dr Wale Oke (now a Bishop), I was one of those that responded to the altar call and gave my life to our Lord Jesus Christ.

At that   meeting, I also registered as a member of the Fellowship. After that, I realised that, until that memorable day that I gave my life to Christ, I had been an idol worshipper, not better than those old people in my village with wooden idols in their homes.

NAFDAC Warns Against Consumption of Australian Apple-Blackcurrant Juice

0

The National Agency for Food and Drug Administration and Control (NAFDAC) has recently warned Nigerians not to consume “Pure Tassie Organic Apple and Blackcurrant Juice”, which has its origin in Australia.

Prof. Moji Adeyeye, NAFDAC Director-General, who issued the warning through the News Agency of Nigeria (NAN), revealed that the products had been certified harmful for human consumption.

She added that the Centre for Food Safety (CFS) of Hong Kong’s Food and Environmental Hygiene Department has also warned against the consumption of the product.

Avoid black currant juice

“This was due to unacceptable level of patulin (a mycotoxin) which has exceeded the maximum limit in fruit juice,” she said.

The NAFDAC DG further added that the level of patulin content in the affected fruit juice can induce liver spleen and kidney damage.

She also noted that the toxic level will compromise the immune system and cause nausea, gastrointestinal disturbance and vomiting.

Adeyeye also implored importers, distributors, retailers and consumers to immediately stop the importation, distribution, sale and consumption of the affected fruit juice.

She equally urged members of the public in possession of Pure Tassie fruit juice to submit it to the nearest NAFDAC office.

She also called on healthcare professionals and consumers to report adverse events related to the use of the product to the nearest NAFDAC office through NAFDAC PRASCOR (20543 TOLL FREE from all networks).

Adeyeye also said the agency could be reached through pharmacovigilance@nafdac.gov.ng or through the NAFDAC ADR e-Reporting platform available at www.nafdac.gov.ng.

 

AstraZeneca COVID-19 Vaccine gets NAFDAC’s Approval

0

Director General, National Agency for Food and Drug Administration and Control (NAFDAC) Prof. Moji Adeyeye says the agency has approved the AstraZeneca COVID-19 Vaccine for use in Nigeria.

She made the announcement Thursday morning in a live briefing held in Abuja, saying the vaccine can be stored at 2 to 8-degree centigrade.

The World Health Organization (WHO) gave emergency use approval to AstraZeneca’s COVID-19 vaccine on Monday, allowing distribution to some of the world’s poorest countries to begin.

Prof. Moji Adeyeye

NAFDAC DG says it got the dossier of the vaccine a week ago, and the agency’s safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
Adeyeye however explained that three other vaccines are currently undergoing evaluation by her safety team in addition to the over 30 herbal medicines under review for listing by the agency.

She said the evaluation on Astrazeneca shows that the vaccine is effective against the United Kingdom variant of the virus which has been reported in Nigeria.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19)

With the emergency use approval granted the AstraZeneca vaccine in Nigeria, it becomes the first COVID-19 vaccine to be approved in the country.

All of the following statements concerning vitamin B2 functions are true EXCEPT:

3

All of the following statements concerning vitamin B2 functions are true EXCEPT:

a) Essential constituent of flavoproteins, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD)

b) Plays key roles in hydrogen transfer reactions associated with glycolysis, TCA cycle and oxidative phosphorylation

c) An essential coenzyme for oxidative decarboxylate of alpha-keto acids, most important being conversion of pyruvate to acetyl coenzyme A

d) Deficiency symptoms are cheilitis, cheilosis and angular stomatitis

PCN, NAFDAC Championing Availability of Quality Medicines in Africa – Prof. Anyakora

0

As Nigerian pharmacists, scientists and other relevant stakeholders continue to work towards the attainment of excellence in drug production and distribution, eminent Professor of Pharmaceutical Chemistry and Chief Executive Officer of Bloom Public Health, Chimezie Anyakora, has said that the Pharmacists Council of Nigeria (PCN) and the National Agency for Food and Drug Administration and Control (NAFDAC) are working harmoniously to ensure that quality medicines are provided for Nigerians and other Africans.

Speaking to Pharmanews, in an exclusive interview, the internationally-recognised academic and former country lead (Nigeria) for the United States Pharmacopoeia, stated that NAFDAC is highly respected in the West African sub-region and indeed the African continent as a whole. According to him, the Nigerian food and drugs regulator is the backbone of the regional harmonisation happening in ECOWAS.

Anyakora added that in order to sustain the availability of quality medicines in Nigeria and beyond, the Good Manufacturing Practice (GMP) roadmap which he conceived and shared with NAFDAC must be implemented to the letter. He noted that the aim of the initiative is to improve the overall quality of local manufacturing and put Nigeria in a leading role in pharmaceutical manufacturing across Africa.

Prof. Chimezie Anyakora

Below is the full interview:

Sir, you have been involved in public health and quality medicine research. Can you tell us how your works have impacted the Nigerian health sector?

I have dedicated a large chunk of my professional life to this field and it is most rewarding to see what we have been able to achieve in a few years, in partnership with other well-meaning Nigerians. As a key player in this sector, I think we have not fully captured all the improvements that have been made in the medicine quality space in Nigeria. Several new factories have come up in the last ten years. NAFDAC is much more respected on the continent. As a matter of fact, all the NAFDAC labs are ISO 17025 accredited.

NAFDAC technical staff are the backbone of the regional harmonisation happening in ECOWAS. NIPRD has come out much stronger than they used to be and they currently play great roles in the pharmaceutical space. Their drug lab is also ISO 17025 accredited. PCN is working harmoniously with NAFDAC to ensure the availability of quality medicines throughout the medicine supply chain.

Many pharmacy schools in Nigeria now actively prepare their students to be ready to contribute to the quality assurance system of the country. There is a much more sustained effort to have local companies play in the public health programmes. Some companies in Nigeria are supplying products to the world for public health programmes.

Nigerian manufacturers have stepped up to be counted in the public health space. A Nigerian company was the first on the continent to produce chlorhexidine gel for umbilical cord care. A Nigeria company was the first on the continent to produce oxytocin injection for postpartum haemorrhage. A Nigerian company was the first on the continent to produce amoxicillin dispersible tablet. A Nigerian company was a major supplier for Zn dispersible tablets used in many African countries for public health programmes. We can go on and on. All these happened in the last five years and we are not shouting enough.

As someone immersed in all these improvements in the country I always look back with so much joy on what has happened in this country in such a short space of time and l look at the future with much more excitement because I know we are going to achieve much more. Nigeria will be among the top five countries in the world in pharmaceutical manufacturing in the foreseeable future and certainly the first in Africa. When I see all this I feel we are not shouting enough.

Can you take us on an excursion into the Bloom Public Health vision and mission and how you plan to better the lot of the Nigerian health sector?

Bloom Public Health has come to further advance all these gains over these years. Bloom Public Health exists to bridge the gap in public health in Africa and create a continent where access and quality of care are affordable to all in a sustainable way. Over these years of playing in the public health space on the continent, one thing that became clear was the immense talent available on the continent, yet so uncoordinated.

We do not lack the necessary talents but we just need to marshal them towards the solutions for public health. This is the essence of Bloom Public Health – to mobilise local talents on the continent for a sustainable public health impact. We cannot continue to rely on the West to solve our problems.

The GMP roadmap for the Nigerian pharmaceutical industry has been widely applauded for its objectives and you have been credited to be the brain behind it. How well do you think this roadmap has been embraced so far?

I think the GMP roadmap is one biggest achievement of my career. The impact will last for years to come. That is the beginning a great renaissance in the pharmaceutical sector in Nigeria. By the time we look back, five to ten years from now, we will realise how important this activity is.

I really want to applaud NAFDAC for that bold step and the PMGMAN for a great buy-in. Of course, I also appreciate my former employer, the United States Pharmacopeia, through the PQM programme funded by USAID, for being an instrument to make this project happen in Nigeria.

The story is just beginning. Everyone has to embrace it eventually. It took a lot of advocacy for it to happen. Everyone resisted it but I saw the impact and never stopped pushing for it. It took several years to achieve the necessary buy-in for it to happen. I think at this stage, it will necessarily take its course. As a matter of fact, the Pharmacity concept that Bloom Public Health is also pushing – thanks to our partnership with the National Association of Industrial Pharmacists (NAIP) – is part of the fruits of the roadmap.

As a necessity, many company will have to upgrade. The Pharmacity gives them the alternative to do that in an environment with the best of support system anyone can think of and the cheapest possible cost of manufacturing anywhere in Nigeria because of the incentives and the benefit of economy of scale.

We are on the verge of a great renaissance in the pharmaceutical sector in Nigeria. Another fruit of the roadmap is a very important project being championed by Bloom Public Health, in partnership with the PCN, NIPRD and the Lagos Business School. We are trying to map out the pharmaceutical value chain, the size of the market and the growth potential.

The aim is to attract investors to the pharmaceutical ecosystem. One of the biggest problems of pharmaceutical manufacturing in Nigeria is that there is no lively ecosystem to support quality manufacturing. Every service is practically procured from outside the country. This our project will populate the ecosystem and thereby set up the sector for growth.

The pharmaceutical manufacturing landscape in Nigeria is saturated with all shades of players. How do you think NAFDAC and all other stakeholders can ensure that the health of Nigerian citizens is safeguarded to the letter, bearing in mind the threats posed by manufacturers of fake and substandard products?

As I always like to say, it is good to categorise substandard medicines into two. One is poor quality, due to lack of expertise in pharmaceutical manufacturing and storage. The second is poor quality due to criminality because of falsification of products. The two are solved differently. The GMP roadmap is solving the former. With the roadmap, every company knows where they stand and what they need to do to be where they should be.

The latter requires a combined effort to combat. Not only NAFDAC – everybody should keep an eye. If you see something, say something. Even though NAFDAC is among the most populated medicine regulatory authorities on the continent, they also have an enormous task to regulate such a wild environment and we should all support with the necessary information. And gradually the bad actors will not find it conducive to operate.

What should Nigerians expect from your collaboration with the National Association of Industrial Pharmacists?

So far, this has been amazing. The first fruit of our collaboration is the Pharmacity, which is about to go live. This is what it means to be aligned to a common goal. I want to use this opportunity to appreciate the leadership of NAIP. They have made this collaboration wonderful and we are achieving a lot together.

The second wave of the coronavirus has shown that the pandemic is very much with us. What is Bloom Public Health doing to help in the fight against the virus?

Bloom is playing big in this pandemic too. Firstly, we have been advocating for local manufacture of medicines in the country, taking advantage of what the pandemic has thrown up, which is an unsustainable structure of reliance on foreign countries for our medicines needs.

Bloom is also playing big in the vaccine policy that the government of Nigeria is developing. We are a key partner to the Ministry of Health in this project, with other organisations like WHO, UNICEF and CHAI. Bloom is also part of the COVID-19 vaccine introduction Technical Working Group. We also partnered with the Medical Lab Science Council of Nigeria and the Nigerian National Accreditation System to build capacity of labs towards accreditation on serologic and biologic molecular test methods.

Apart from Bloom Public Health, which other project are you involved in?

Firstly, I am an academic and will always be. I have a great advantage of viewing things with a certain depth, typical of an academic; and having a strong hands-on knowledge and understanding of things, typical of a practitioner. I know this is a unique combination that is somehow rare.

I have also been deeply involved in international development programmes, as well as a deep involvement in the pharmaceutical sector. This is unique and I bring that with my passion for excellence and great patriotism to push the country forward to the best of my ability.

Apart from Bloom Public Health, I am the founder of CAROSS, the Centre for Applied Research on Separation Science. Here, we mentor young academics to excel in research by providing them with the necessary contacts, tools and motivation to do so. We also give out an annual prize to young chromatography scholars each year. I am also a cofounder and vice chairman, board of trustees, of Safe Medicine Foundation, a non-governmental organisation doing a lot in promoting medicine quality in Nigeria. I sit on a few other boards in different organisations, both in Nigeria and outside Nigeria.

What is your advice to Nigerian healthcare practitioners in the face of the ravaging coronavirus pandemic that has led to adverse social and economic restrictions?

We should all focus on the lessons we can learn from this pandemic. We cannot afford not to learn from this. Also, it is good to see the great work done by the Nigerian healthcare practitioners and we should make it a norm and maintain the tempo, even when the pandemic goes away.

COVID-19: UN Urges G20 to Prepare ‘Global Vaccination Plan’

0

The UN Secretary-General, Antonio Guterres, on Wednesday proposed that the Group of 20 set up an emergency task force to prepare a ‘Global Vaccination Plan’ against COVID-19.

He told an open debate of the Security Council on “ensuring the equitable access to COVID-19 vaccines in contexts affected by conflict and insecurity”.

“We have come together to create the COVAX facility, the one global tool to procure and deliver vaccines for low- and middle-income countries.

The UN chief Antonio Guterres

“COVAX requires to be fully funded.

“But we must do even more; our efforts need to be comprehensive and well-coordinated everywhere,” said Guterres.

“The world urgently needs a Global Vaccination Plan to bring together all those with the required power, scientific expertise as well as production and financial capacities.

“I believe the G20 is well placed to establish an emergency task force to prepare such a global vaccination plan and coordinate its implementation and financing.’’

This task force should include all countries capable of developing vaccines or to produce them if licenses are available, together with global vaccination organisations, other relevant technical organisations and international financial institutions.

The task force would have the capacity to mobilise the pharmaceutical companies and key industry as well as logistics actors, he said.

“I am ready to galvanise the full UN system in support of this effort.

“The G7 (Group of Seven) meeting later this week can create the momentum to mobilise the necessary financial resources,” said the UN chief.

At this critical moment, vaccine equity is the biggest moral test facing the global community, he said.

“We must ensure that everybody, everywhere can be vaccinated as soon as possible.’’ 

(NAN)

Air Pollution Caused 160,000 Deaths Last Year –Group

1

Serious pollution caused around 160,000 premature deaths in the world’s five most populous cities last year, even as air quality improved in some places due to coronavirus lockdowns, an environmental group said on Thursday.

The worst-affected was New Delhi, the most polluted capital on Earth, where around 54,000 deaths are estimated to have occurred due to hazardous PM2.5 airborne particles, according to a report from Greenpeace Southeast Asia.

Air Pollution Caused 160,000 Deaths Last Year –Group
Air Pollution Caused 160,000 Deaths Last Year –Group

In Tokyo, the figure was 40,000 with the rest spread across Shanghai, Sao Paulo and Mexico City, according to the report, which looked at the impact of microscopic PM2.5 matter produced by burning fossil fuels.

“When governments choose coal, oil and gas over clean energy, it’s our health that pays the price,” said Avinash Chanchal, climate campaigner at Greenpeace India.

PM2.5 particles are considered the most harmful for health. They damage the heart and lungs and increase the chances of severe asthma attacks.

Some studies have linked PM2.5 exposure to a higher risk of dying from COVID-19.

The report used an online tool that estimates the impacts of PM 2.5 by taking air quality data from monitoring site IQAir and combining it with scientific risk models, as well as population and health data.

The tool is a collaboration between Greenpeace, IQAir, and the Centre for Research on Energy and Clean Air.

Despite the high numbers of deaths, coronavirus lockdowns imposed across the world — that took traffic off the streets and shut down polluting industries — did temporarily clear the skies above big cities.

Delhi, for instance, underwent a dramatic transformation for a period last year when curbs were imposed, with residents revelling in azure skies and clean air.

Scientists say that massive drops in some pollutants due to lockdowns are bound to have prevented deaths.

Nevertheless, Greenpeace urged governments to put investment in renewable energy at the heart of plans to recover from the pandemic-triggered economic downturn.

“To really clean up our air, governments must stop building new coal plants, retire existing coal plants, and invest in clean energy generation, such as wind and solar,” said the group’s air pollution scientist Aidan Farrow.

(AFP)

All of the following effects are disadvantages of anticancer drugs, EXCEPT:

4

All of the following effects are disadvantages of anticancer drugs, EXCEPT:

a) Low selectivity to cancer cells

b) Depression of bone marrow

c) Depression of angiogenesis

d) Depression of immune system

Nigeria Records 1,368 New COVID-19 Infections, 16 Deaths in 24-Hours

1

The Nigeria Centre for Disease Control has recorded 1,368 new cases of COVID-19, bringing the total number of infections in the country to 148,296.

The NCDC disclosed this on its official Twitter handle in the early hours of Wednesday. 

The News Agency of Nigeria reported that the new infections registered today doubled the 574 cases reported on February 15. 

The agency also registered 16 COVID-19 deaths, raising the total fatality in the country to 1,777.

It stated that the 1,368 new infections were reported from 27 states and the Federal Capital Territory.

The NCDC stated that Anambra State registered the highest infections for the first time since the pandemic broke out in February 2020, in the country. 

It noted that of the 1,368 new cases, Anambra posted 344 cases, despite not recording any case the previous day, followed by Oyo State which also witnessed a rise in infections after recording 172 cases and the FCT in the third position confirmed 148 infections. 

The agency noted that 107 cases of the virus were found in Benue state, Rivers had 95, Ogun-59, Ondo-56, Ebonyi-53, Kaduna-52, Plateau-46, Kwara-36 and Enugu-30.

NCDC stated that data from Enugu State covered the last two days and a backlog of deaths reported from Abia State.

Other states with registered cases were Akwa Ibom-26, Osun-22, Edo-20, Abia-17, Kano-16, Borno-15, Cross River-10, Delta-8, Gombe-8, Imo-7, Ekiti-5, Sokoto-4, Jigawa-3, Bayelsa-3, Nasarawa-3 and Zamfara-3.

The public health agency stated that at least 1,474 people had recovered and been discharged from isolation centres across the country in the last 24 hours, bringing the total number of people who had been discharged after recovery to 124,483.

It noted that the discharged recorded on Tuesday included 762 community recoveries in Anambra State, 132 in Plateau and 126 in FCT.

It said that a multi-sectoral national Emergency Operations Centre activated at Level 3 is coordinating response activities nationwide.

The agency said that there were now 22,036 active cases across the country. 

NAN recalls that the country has tested 1,441,013 people since the first confirmed case relating to the COVID-19 pandemic was announced on February 27, 2020.

(NAN)

Diabetes Drug May Help Reduce Weight, Study Suggests

2

A drug used in the treatment of Type 2 diabetes has been found to be very effective against obesity.

Scientists say that the drug, Semaglutide, may help obese persons avoid consequences of obesity such as diabetes and hypertension, according to a study published in the New England Journal of Medicine in London.

Semaglutide is currently marketed as a treatment for Type 2 diabetes by its manufacturer, Novo Nordisk.

After manufacturers noticed that patients taking the drug lost weight over the course of treatment, researchers at Northwestern University decided to test its effectiveness at a much higher dose against obesity.

The study, conducted at 129 centres in 16 countries, included nearly 2,000 people with obesity, who injected themselves on a weekly basis with either semaglutide or a placebo for 68 weeks.

Both groups also received diet and exercise counseling during the study.

Researchers found that on average, individuals who received doses of semaglutide lost close to 15 percent of their body weight, while individuals who received the placebo lost 2.4 per cent of their body weight.

More than a third of participants who received semaglutide lost more than 20 percent of their body weight.

“This is the breakthrough in weight management that obesity patients have been waiting for,” said Thomas Wadden, a professor of psychology at the University of Pennsylvania and a co-author of the paper.

“I’ve been working at Penn for 40 years in weight management and this is one of the most exciting developments I’ve seen over the course of my career.”

The results are especially intriguing now as obesity is considered a significant risk factor for COVID-19 complications.

Most obesity medications currently approved by the Food and Drug Administration (FDA) lead to around a 7 per cent reduction in body weight.

With that amount of weight lost, “many people will still feel overweight even if they’ve improved their health,” he said.

Patients who took semaglutide in the study experienced only mild gastrointestinal symptoms, such as nausea and diarrhea, compared to obesity medications in the past.

Wadden also pointed out that obesity medications currently approved for use can only be taken for a short period of time, while researchers visualize prescribing semaglutide as a medication for a chronic condition.

Additional studies are being conducted to determine the effectiveness of an increased dose of the drug in patients with Type 2 diabetes, who were not included in this study, as well as how well it maintains weight loss in patients.

“Patients are expected to be able to take these medications in the long term in the same way they take medications for cholesterol and diabetes,” Wadden said.

“This is not something you take for four months and stop. Health care providers need to recognize that this is a chronic treatment for what is a chronic health problem.”

But it’s important not to overlook the lack of research on semaglutide’s long-term effects, said Farzaneh Daghigh, a professor of biochemistry at the Philadelphia College of Osteopathic Medicine, who was not involved with the study.

The drug is a synthetic version of a hormone that produces feelings of fullness in the brain and the gut.

Daghigh said the medication is likely to be expensive, pointing out that the lower dose of semaglutide currently prescribed for patients with Type 2 diabetes costs 1,000 dollars a month.

She also cautioned that the study was funded by the drug’s maker, Novo Nordisk.

“When these types of pharmaceutical therapies come out, we scientists like to see independent groups do this study,” she said.

Daghigh stressed that it’s also important to teach people how to eat healthier foods and plant-based diets, instead of relying on drug therapies to address obesity.

“I can see the advantage of using this for certain patients, but you can’t inject the drug forever,” she said.

“If the patients don’t know how to manage themselves after, that’s a problem. All that makes me very hesitant to cheer.”

But Wadden hopes the results of the study will accelerate research into obesity medications.

“The average patient in this study lost 30 pounds,” he said.

“This is a significant milestone because a person can then attain greater control of obesity-related health complications, like hypertension, blood sugar and sleep apnea.

People feel like they look different, feel different, can exercise more comfortably, buy clothing they find more attractive and play with their children and grandchildren.”

(dpa/NAN)

WTO Can Help Drive Global Vaccine Access –Okonjo-Iweala

1

Newly elected head of the World Trade Organisation, Ngozi Okonjo-Iweala, said on Tuesday she will push for concrete results in addressing the dual economic and health crises facing the globe.

Her immediate goals are to ensure COVID-19 vaccines are produced and distributed worldwide, not just for rich nations, and to resist the push towards protectionism that worsened during the pandemic so that free trade can help the economic recovery.

“I think the WTO is too important to allow it to be slowed down, paralyzed and moribund,” she told AFP in an interview. “That’s not right.”

She will take over leadership on March 1 of an institution that has become weighed down and increasingly defanged, especially by the open hostility of Donald Trump’s administration.

Amid the turmoil, including the US move that shut down the dispute resolution court in December 2019 about complaints about the handling of disputes with China, her predecessor stepped down last August, a year before his term was up.

WTO Can Help Drive Global Vaccine Access –Okonjo-Iweala
Ngozi Okonjo-Iweala

Selected by the membership on Monday, after US President Joe Biden’s administration backed her candidacy, Okonjo-Iweala promised to breathe fresh life into the trade body which she says has lost focus on helping improve living conditions for real people.

“I believe the WTO can contribute more strongly to a resolution of the COVID-19 pandemic by helping to improve access accessibility and affordability of vaccines to poor countries,” she said.

“It’s really in the self-interest of every country to see everyone vaccinated because you’re not safe until everyone is safe.”

Some countries, such as India and South Africa, have been pushing for a suspension of trade rules on patents to allow more rapid vaccine rollout.

But rather than get caught in another squabble among WTO members, Okonjo-Iweala said the organisation could promote a quicker path.

“Instead of spending time arguing on those, we should look at what the private sector is doing” with licensing agreements, to allow vaccines to be produced in multiple countries – something she noted AstraZeneca already has done in India.

“The private sector has already looked for a solution because they want to be part of reaching poor countries and poor people,” she said.

In addition, the WTO needs to work to ward off the trend towards export restrictions for medical devices and therapeutics, as well as the possibility of restrictions on the vaccines themselves.

While it is natural for politicians to help their own countries first, she warned that supply chains are tightly linked and cannot be quickly disentangled to create all-domestic production.

The MIT-trained economist, who served as Nigeria’s first woman and longest-serving finance minister, who also is a US citizen, is adamant the WTO must return to its original function of helping countries to deliver better living standards to their people.

“It’s about creating employment, decent work for people. It’s about … improving lives,” she said.

“There is definitely a role for trade to play in the recovery” from the COVID-19 economic crisis.

Even before the pandemic sparked a global recession, the organisation had lost sight of that goal, she said, lamenting the example of the negotiations over a fisheries subsidies agreement that has dragged on for two decades.

“This cannot go on. We must bring it to a conclusion. We can’t afford to fail on this.”

The talks, which aim to end subsidies that lead to overfishing, failed to yield an agreement by the end-2020 deadline.

She blamed some of the calcification on the dominance of negotiators, which she called an “Achilles heel” of the WTO.

“Geneva is full of negotiating experts, but the problems have not been solved they’ve gotten worse,” she said. “For them, it’s all about winning or not losing and so they stalemate each other.”

The WTO needs “something entirely different” to turn things around, she said, rejecting criticism from some sectors that she lacks trade experience.

“You need strong political skills you need the ability to manoeuvre,” she said, adding that she can serve as a bridge between developed and developing nations, pulling on her 25-year career at the World Bank as well.

She also intends to push to schedule the pandemic-delayed WTO ministerial meeting by the end of this year to start which will allow her to spark a movement on critical issues.

Okonjo-Iweala will once again be the first woman in a key leadership role, taking over the WTO for a term that runs through August 31, 2025, but is renewable.

She agreed it was a challenging, thankless job, but said that makes her even more passionate to show results so that in future no one can question placing a woman in the role. 

“That means I need people to support me even more. I need more cooperation,” she said.

(AFP)

COVID-19, Influenza and Sanofi’s Innovative Flu Vaccine

4

The coronavirus pandemic, which took the world by surprise, exposed the underbelly of the health systems worldwide. Healthcare systems in advanced economies such as Italy, Spain, US, France, etc. were quickly overwhelmed as tens of millions of residents in these countries caught the virus leading to the death of millions. In US, for instance, more than 27 million people had been infected as of 15 February, with close to half a million reported dead from the virus.

Africa, particularly Nigeria, has been inexplicably fortunate with COVID-19 in terms of infection and death rates. There had been fears at the outset of the virus in Nigeria that it would not only overrun the country’s fragile health system but that hundreds of thousands of lives or possibly millions might be lost to the virus. That has not happened though and is very unlikely it would. As of 15 February, almost a year since the virus got into the country, fewer than 200,000 infections had been recorded and only about 1,747 lives, unfortunately, had been lost. No doubt, as a nation, and a global community, we are facing extraordinary times as a result of COVID-19.

Despite the relative low spread of the virus, there is a real threat of the second wave of the pandemic, with new strains, becoming far more dangerous. This is so because the second wave is coinciding with the upcoming flu season, which would place huge pressure on an already-stretched health system.

The flu or influenza season is usually the cold wet periods during the rains. So, how is the cold, flu season of any relevance to COVID-19? The seasonal influenza is presented much the same way as the coronavirus. Viruses seem to thrive in temperate climate. The flu, like COVID-19, is a viral infection that attacks the respiratory system. And like the coronavirus, it is airborne and can be transmitted via droplets as we speak, sneeze or cough. It is a serious condition that can lead to severe complications such as heart attacks and strokes and has a huge human, societal and economic impact.

Flu is a contributing factor to five out of the top 10 deaths globally, with 3 to 5 million severe influenza cases reported worldwide. The World Health Organisation (WHO) estimates that flu may be responsible for an estimated 290,000 to 650,000 respiratory deaths per year worldwide, with a global burden of about 10 million influenza-related hospitalisations every year.

According to a recent study, one is 10 times more likely to have a heart attack in the week after being diagnosed with the flu and eight times more likely to have a stroke. People over 65 years of age are most susceptible to flu and its complications, because the immune system deteriorates with age (immunosenescence), experiencing a higher risk of influenza-associated morbidity and mortality. 50%-70% of hospitalisations occur in people aged over 65 and 70%-85% of flu-related deaths occur in this age group.

Those with other chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), heart disease and diabetes are at greater risk of flu-related complications than the general population. For example, people with heart conditions are 10 times more likely to die from flu complications and diabetes triples the risk of hospitalisation for flu complications and quadruples the risk of intensive care unit (ICU) admission once in hospital. Furthermore, flu can cause increased exacerbations in asthma and COPD patients.

Because age increases susceptibility to infection, older adults are the most at risk for influenza infection and serious outcomes. Influenza infection can contribute to functional decline, or a senior’s inability to recover back to full prior functional capacity once the infection has passed. Adults aged over 65 represent 9 in 10 influenza-related deaths and 63% of influenza-related hospitalisations.

As we approach the flu season, however, we need not panic because the good news is that there are vaccines that are readily available to protect against influenza. And the vaccines are fairly effective against the different strains of the flu. The Nigerian Centre for Disease Control (NCDC) has been encouraging Nigerians to take the flu vaccine. According to NCDC, the flu vaccination is particularly critical this season because the flu and COVID-19 cause similar symptoms. So, getting the flu shot could reduce symptoms that could be mistaken for those caused by COVID-19.

Indeed, flu vaccination is still the most effective way to protect yourself, those around you who may be more vulnerable to the disease and the wider economy. Flu vaccination is especially important for people at high risk of flu complications, and for people who live with or care for the people at high risk. These include pregnant women at any stage of pregnancy, children aged between 6 months and 5 years, elderly individuals with chronic medical conditions, individuals, including young people, with chronic medical conditions, and healthcare workers. The WHO thus recommends annual vaccination for these group of people, especially, and for everyone else.

Viruses mutate, however, and develop new strains that may be resistant to vaccines not specifically developed for such new strains. Thus, there is often the concern that a particular flu vaccine may not be effective enough against certain types of flu.

Sanofi Pasteur, the world’s largest manufacturer of innovative influenza vaccines, may have addressed these worries with its newly developed influenza vaccine. Sanofi has for decades been offering effective vaccines to protect people at every stage of life, including over 65s, at-risk groups and the general population. The company now produces more than 220 million doses of seasonal influenza vaccine, representing a significant proportion of the global supply.

Sanofi Pasteur said the new influenza vaccine uses recombinant technology, the first to do so. Recombinant technology is a precise and innovative manufacturing process which generates an exact genetic match to the selected influenza virus strains. Large clinical trials have shown that recombinant quadrivalent (QIVr) provides greater coverage and protection for the under 65s at-risk populations and has proven efficacy and safety. Quadrivalent influenza vaccine (QIV) is a well-established standard dose quadrivalent suitable for under 65s with or without comorbidities, pregnant women, healthcare workers and ex-COVID patients.

With COVID-19 ravaging the country and the seasonal influenza soon to join, you don’t want to take chances with your health and those of your loved ones. And you don’t want to have the flu and people confuse it for COVID-19. Neither do you want to be susceptible to COVID-19 through the flu, which is why it is essential you do whatever you can, including getting vaccinated, to avoid contracting the flu this season. Now is the time to act by asking your doctor for a flu vaccine shot.

‘Access to Condoms Will Check Sexually-Transmitted Infection Rate’

2

Experts on Saturday advocated equitable access and increased use of condoms to prevent Sexually Transmitted Diseases and for family planning.

The experts made the call during a tweet meet organised by AIDS Healthcare Foundation, in collaboration with NACA and Premium Times Centre for investigative Journalism, in commemoration of 2021 International World Condom Day.

The News Agency of Nigeria reports that ICD is celebrated on February 12, to raise awareness and promote the use of condom as a preventive measure against sexually transmitted infections.

Prevention Programme Manager at AHF Nigeria, Mr. Taofeek Adeleye, said on his official Twitter handle that the organisation had ensured people were aware of condom use.

According to him, the organisation did this by providing access to free condoms through condom dispensers installed at strategic locations.

Adeleye said such was necessary as the total market approach on condom use was to increase access in order to prevent HIV/AIDS and sexually transmitted infection.

Adeleye explained that there was no need to use both the male and female condom at the same time, adding that correct and consistent use was key in ensuring safety.

He warned that condoms have expiry date, noting that the average shelf life of condom is five years from the time of manufacture, adding that when expired, it is not desirable for use as it’s quality would be compromised.

He further stressed that other factors that could compromise the quality of condoms include improper storage and use, saying they should be kept at room temperature.

National Coordinator of CISHAN, Mr. Walter Ugwuocha, on his official Twitter handle, tweeted that his organisation had trained various community-based organisations on condom sensitisation and demonstration.

He said: “That they will ensure every community member is aware of both male and female condoms and their use.”

Chief Programme Officer, Community Prevention and Care Services at NACA, Mr. Kingsley Essomeonu, tweeted that NACA has provided coordinated policy and programme environment for condoms and lubricants in the national HIV response.

Essomeonu, however, tweeted that the government frowned at condom as part of HIV and SRH education, but dissemination of information about condom is done through radio and television.

(NAN)

Pharmanews Nominee Graduates with Over 50 Published Research Articles, Bags 1st Class

70

Pharm. Adebisi Yusuff Adebayo, a Pharmanews nominee who took second position in the Pharmanews PANSite of the year 2019 Online Poll, with 1,342 votes, has recently bagged a First Class honours in Pharmacy, from the University of Ibadan (UI) as well as published over 50 research articles.

He was one of the 65 inductees of the Pharmacy Faculty of UI who were recently inducted by the Pharmacists Council of Nigeria (PCN) into the Profession. It is quite astonishing how well-involved Adebayo was in many extra-curricular activities and his achievements throughout his stay in the University.

Pharm. Adebisi Yusuff Adebayo

Adebayo is the Director for Research at Global Health Focus, an organisation that seeks to build critical thinkers and leaders in global health towards achieving health-related Sustainable Development Goals.

He also functions in the following positions: Director for Research and Innovation at the African Young Leaders for Global Health; Coordinator at AB Global Health Initiative; Co-founder and Executive Director at Pharmacostory (a community of young leaders dedicated to health promotion), and the Director of Healthy Nations Initiative (a community empowerment think-tank aimed at improving access to health information.

Adebayo is a global health enthusiast, drug policy advocate, research enthusiast, and public health educator. He has published over 50 articles (in different international peer-reviewed journals) in the areas of global health and public health, with more than 200 Google Scholar Citations as an undergraduate.

He has presented (as author/co-author) various research publications in many local and international conferences. His team won the 2018 Innovate4AMR global competition organised by World Health Organisation, John Hopkins University Bloomberg School of Public Health, South Centre, ReAct -Action on Antibiotics Resistance and the International Federation of Medical Students’ Association.

Pharm.Adebayo is also a Royal Society of Tropical Medicine and Hygiene UK Ambassador, Tobacco Harm Reduction Scholar for Knowledge-Action-Change London, drug policy and harm reduction advocate at Student for Sensible Drug Policy Washington D.C, United States.

He was awarded the National Institute of Health Research UK and RSTMH grant to carry out a project on risk communication and community engagement strategies, surveillance and laboratory testing capacity for COVID-19 in selected African countries.

The management and staff of Pharmanews wish him all the best as he embarks on his success journey.

Low-density lipoprotein (LDL) is:

2

Low-density lipoprotein (LDL) is:

a) A lipoprotein that contains relatively high amounts of cholesterol and is associated with an increased risk of atherosclerosis and coronary artery disease. It is also called beta-lipoprotein

b) A lipoprotein that contains relatively small amounts of cholesterol and triglycerides and is associated with a decreased risk of atherosclerosis and coronary artery disease. It is also called alpha-lipoprotein

c) A lipoprotein containing a very large proportion of lipids to protein and carrying most cholesterol from the liver to the tissues

d) Large lipoprotein particle that is created by the absorptive cells of the small intestine. It transports lipids to adipose tissue where they are broken down by lipoprotein lipase

Death of 24 COVID-19 Patients Evidence Virus Still Around, FG Warns

1

The Presidential Task Force on coronavirus COVID-19 says the deaths of 24 COVID-19 patients in a day should be a wake-up call to Nigerians that the deadly virus is still around.

The task force noted that the number of deaths, reported by the Nigeria Centre for Disease Control on February 13, was the second highest in a day since the country had its index case on February 27, 2019.

PTF chairman, Mr. Boss Mustapha, said this on Monday in Abuja while speaking at the national briefing of the PTF on COVID-19, the News Agency of Nigeria reported.

Death of 24 COVID-19 Patients Evidence Virus Still Around, FG Warns
Death of 24 COVID-19 Patients Evidence Virus Still Around, FG Warns

He said there had been sustained efforts by sub-national entities and the Federal Capital Territory administration to stem the tide against the second wave of the pandemic.

“This is evident in the closure of some facilities, including event centres and clubs, over the violation of protocols.

‘“We are glad with the direction of the collaboration and enforcement which we believe will deter other would-be violators.

“’For the avoidance of doubt, places of worship should only have 50 per cent of their capacity; while indoor gatherings and meetings should not exceed 50 people at a time.

“Indoor restaurants, clubs and lounges should remain closed,” he said.

Mustapha, however, said that the recorded deaths of 24 COVID-19 patients in the country on February 13, being the second highest in a day since the beginning of the pandemic, should serve as a wake-up call for the populace to brace up for more compliance.

(NAN)

FG Develops Training Manual For COVID-19 Vaccine Handling

3

The National Primary Health Care Development Agency says it has developed training manual for COVID-19 handling and management as it plans to vaccinate 109m Nigerians in two years.

The Executive Director, NPHCDA, Dr. Faisal Shuaib, says the plan is to train healthcare workers, supervisors and monitors at all levels in the next one to two weeks.

FG Develops Training Manual For COVID-19 Vaccine Handling
FG Develops Training Manual For COVID-19 Vaccine Handling

Shuaib disclosed this at the Presidential Task Force on COVID-19 briefing on Monday in Abuja, the News Agency of Nigeria has reported.

The World Health Organisation says all health workers involved in implementation of COVID-19 vaccination need to have adequate knowledge and skills in order to ensure safe and efficient COVID-19 vaccine administration.

The WHO says, “The COVID-19 vaccination training for health workers package is developed for frontline health workers in countries.

“The package, developed in collaboration with UNICEF, consists of six modules, which include video lectures, quizzes, job aids, interactive exercises and downloadable presentations with the available information.”

Shuaib said, “With the over 60,000 health workers providing routine immunisation services nationwide, we recognise that the COVID-19 vaccine introduction certainly requires capacity building for this health workforce, but in addition to this, we will be engaging additional personnel to achieve the coverage level we desire and also ensure best practice in vaccine handling and management.”

He noted that, consequently, the Federal Government, through NPHCDA, had developed a training manual for the COVID-19 vaccine introduction.

Shuaib said that the manual outlined a comprehensive scheme and measures to identify and develop micro plans for the target population; the development of an effective, efficient and equitable vaccination delivery strategy, while ensuring vaccine security, management and accountability.

“The plan is to train healthcare workers, supervisors and monitors at all levels in the next one to two weeks,” he added.

The NPHCDA boss added that to facilitate the implementation process, the Technical Working Group had come up with a strategy of pre-registration and scheduling of the target population to prevent overcrowding at vaccination posts.

“We have come up with a strategy called the TEACH approach, which will harness all the benefits of traditional, electronic, assisted and concomitant house-to-house registration to optimise the use of innovative technology.

“The TEACH approach entailed:
• T: Traditional method of vaccinating target populations using desk review of available data sources, identifying the vaccination sites and rolling out
• E: Electronic self-registration for health workers and the public; a link which provides an online form will be provided
• A: Assisted electronic registration
• C: Concomitant e-registration during a walk in to fixed sites/health facilities
• H: House-to-House registration using volunteers for an additional push to rapidly increase the e-registration

“A URL link will be deployed for the electronic registration tool, which will be rolled out this week for healthcare workers, to register and appropriately schedule them for the COVID-19 vaccination,” he stated.

Shuaib also said that as part of the agency’s risk communication and demand generation strategy, it had organised a two-day training for over 1,500 LGA health educators and Community Orientation Mobilisation Officers of the National Orientation Agency.

This was to enable them to conduct community polling, track rumours and provide accurate information on COVID-19 vaccine to community members, he added.

“We also continued our sensitisation meetings with a wide range of stakeholders, which include the Association of Community Pharmacists of Nigeria, the Soroptimist International, and the Nigeria Association of Women Journalists.

“They have all shown remarkable willingness to advocate for the acceptance of COVID-19 vaccine,” he said.

He urged Nigerians to be confident that the Federal Government, through the PTF on COVID-19, was doing everything possible to mitigate the resultant complications of  COVID-19 on the health systems and economy.

“It is, therefore, important that we all collectively play our part and adhere to all the measures that are being rolled out to defeat this virus.

“On our part, we will continue to provide you with factual information about COVID-19 vaccine and the vaccination process as things evolve.

“As soon as we get information about vaccine availability timelines, you will also get the same information,” he stated.

(NAN)

Ministry of Health Holds Workshop on Vaccine Policy

0

– As Bloom Public Health, WHO, UNICEF Offer Technical Support

L-R : Dr Joe Adagadzu, WHO consultant; Mrs Olubukola Ajayi, director Food and Drug Services, Federal Ministry of Health; Prof. Chimezie Anyakora, CEO, Bloom Public Health at the workshop in Akwanga, Nasarawa State.

In furtherance of its efforts towards the actualisation of a national vaccine policy, the Food and Drug Services Department of the Federal Ministry of Health has commenced a 5-day workshop aimed at finalising the development of the much anticipated national vaccine policy. 

The event which began on Monday, 15 February 2021,  at Kini Country Guest Inn in Akwanga, Nasarawa State will end on Friday, 19 February 2021. Experts from the World Health Organisation (WHO), the United Nations Education Fund (UNICEF) and Bloom Public Health are on ground to offer technical assistance.

CEO of Bloom Public Health who is also a key person in the project, Professor Chimezie Anyakora, said the policy is aimed at bringing out a clear direction for the country in terms of vaccine use, procurement, selection, manufacturing and research. “This is a very important project in the country. Vaccines are very important in public health. They are the most direct and cost-effective intervention in public health and have created a significant impact on the reduction of diseases globally.

“We need to have medicine security and without vaccine manufacturing in Nigeria, the next pandemic can put over two hundred million Nigerians at great risk. During this pandemic most countries focused on their citizens first and as we can see, Nigeria is not even in the game. With this policy we hope to be better prepared for any future pandemic and also give an opportunity to many Nigerian scientists to put their skills to use for the benefit of their country”, he said.

It would be recalled that Bloom Public Health had recently, in collaboration with the Association of Industrial Pharmacists of Nigeria, unveiled the Pharmacity project in Ebonyi State. The project is famed as the first of its kind in West Africa.

 

NAFDAC Set to Jail Fraudulent Pharmaceutical Importers

0

The National Agency for Food and Drug Administration and Control, NAFDAC has expressed zero tolerance for any unethical act in the clearing of pharmaceutical products, saying any pharmaceutical importer caught with falsified NAFDAC documents will be made to face the wrath of the law.

In reducing the occurrence of fraudulent transactions in the industry, the agency has advised all importers and clearing agents to ensure that they complete every clearing transaction with NAFDAC up to the point of generation of NAFDAC electronic Release Notices.

Speaking in a virtual sensitisation workshop organised by the agency for stakeholders in the Export and Import Trade activities at the nation’s ports which included National Association of Chambers of Commerce, Mine, and Agriculture NACCIMA, Manufacturers Association of Nigeria MAN, Nigeria Customs Service, Standard Organisation of Nigeria SON and Multinationals amongst others; NAFDAC Director General, Prof. Moji Adeyeye, reiterated the stand of the agency against unprofessional acts.

In a statement by the Resident Media Consultant to NAFDAC, Sayo Akintola on Sunday, 14 February 2021, Prof. Adeyeye, said: ‘’We shall take all legal means as an agency set up by the Law of Nigeria to prosecute any erring stakeholder’’.

She reiterated that NAFDAC would not tolerate any unprofessional act from any of its stakeholders be it importers or clearing agents. She added that the disturbing development where agents and possibly with the connivance of importers engage in falsification of NAFDAC documents will not be tolerated nor treated with kid gloves any longer.

Adeyeye urged importers to always ensure that they make it their responsibility to initiate clearance of their goods. The NAFDAC boss advised importers to desist from entrusting the entire process of clearance of their consignments to the agents, stressing that whenever the agents run into trouble with the regulatory authorities, they would always want to cut corners, leaving the importer in the lurch at the end of a botched transaction as a result of failure to meet the requirements of the Agency.

In minimising bottlenecks around registration of products, she said the agency has deployed various improvements in its processes that will ensure auto verification of documents presented to the agency during clearing and place in the hand of stakeholders the ability to verify the true status of clearance of regulated products.

‘’I am happy to state that from wherever in the world, you can process the clearance of your products with NAFDAC without visiting any formation of NAFDAC or Port offices.’’, she said, adding that there have been testimonies of persons in the United States, United Kingdom, India, South Africa who have processed their port clearance documentation with NAFDAC and released their goods without physically appearing at any NAFDAC office except where their clearing agent conducts physical inspection of the products at the ports – ‘’which is the only time you meet any officer of NAFDAC’’.

‘’Many in the past thought that this was not possible but today, we have done over 30,000 transactions released end – to – end automatedly on the PIDCARMS portal since 1st May 2020 till date. All these achievements could not have been achieved without the leadership of the directorate by Professor Adebayo who does not settle for mediocrity but driven for excellence’’, the DG enthused.

Present at the webinar were the duo of Comptroller General of Nigeria Customs Service, Col (rtd.) Hameed Ibrahim Ali and Director General of the Manufacturers Association of Nigeria MAN, Mr Segun Ajayi, who applauded the great initiative of the agency in curbing crimes in the industry. They are pledged their continued partnership with NAFADC with a view to safeguarding the health of the nation.

 

 

 

Sedation, peripheral atropine-like toxicity are possible adverse effects of:

6

Sedation, peripheral atropine-like toxicity (e.g. Cycloplegia, tachycardia, urinary retention, and constipation), orthostatic hypotension, arrhythmias, weight gain and sexual disturbances are possible adverse effects of:

a) Sertaline

b) Amitriptyline

c) Phenelsine

d) Bupropion

PCN Inducts 65 UI Pharmacy Graduands with 22 Distinctions

0

Set to Kickoff Pharm.D Programme

No fewer than 65 graduands of the Faculty of Pharmacy, University of Ibadan (UI), Ibadan, Oyo State, were recently inducted into the Pharmacy profession, by the Registrar, Pharmacists Council of Nigeria (PCN), Pharm. N.A.E Mohammed, at the induction ceremony, held at the Faculty of Pharmacy Auditorium, University of Ibadan, UI, Oyo State, recently.

The low key but colourful induction ceremony, which was hybrid due to the COVID-19 pandemic restrictions, had some dignitaries in attendance, such as Acting Vice-Chancellor, University of Ibadan, Professor Adebola Babatunde Ekanola; Dean, Faculty of Pharmacy, Professor Oluwatoyin Odeku;  Registrar, Pharmacists Council of Nigeria, Pharm. NAE Mohammed, who was represented by Pharm. (Mrs) Yejide Oseni, director, South West, PCN; Pharm. (Mrs) Olatokunbo A. Fagbemi, group managing director and CEO, Nigerian Aviation Handling Company (NAHCO), among many others.

In his address, the Vice-Chancellor of the University, Prof. Ekanola, charged the graduands to be good ambassadors of the institution, adding that they should be found worthy in character and in the discharge of their responsibilities.

PCN Inducts 65 UI Pharmacy Graduands with 22 Distinctions
L-R: Pharm. (Mrs) Yejide Oseni, director, PCN South West Zone; Prof. Oluwatoyin Odeku, dean, Faculty of Pharmacy; Professor Adebola Babatunde Ekanola, Ag. VC, University of Ibadan and Mr A.O. Babalola, Pharmacy Faculty Officer, UI, at the induction ceremony.

The University don, while welcoming and congratulating parents and guardians of the inductees, as well as guests and well-wishers, who linked up virtually to join the occasion, noted that it became necessary to organise the programme as hybrid in line with the conditions prescribed by the University of Ibadan COVID-19 monitoring team.

He continued: “I must salute the courage of the Faculty of Pharmacy staff, led by the Dean, Prof. Odeku, for the unrelenting efforts that have culminated in the success that we are celebrating today. I also commend the Pharmacists Council of Nigeria (PCN), the Pharmaceutical Society of Nigeria (PSN), the Faculty of Pharmacy Alumni Association and other stakeholders involved in training and supporting these inductees” he said.

While presenting the 65 graduands for the oath-taking and induction ceremony, Prof. Odeku, urged the inductees to be worthy ambassadors of the faculty as she urged them to join the Alumni Association, towards contributing to the development of the faculty and the university.

Speaking further, Prof. Odeku who was full of smiles however revealed that the long awaited approval for Doctor of Pharmacy, Pharm. D programme will commence in the 2020/2021 academic session, adding that the programme has been scheduled to commence this month, February, 2021.

While administering the oath, the Registrar, Pharmacists Council of Nigeria (PCN) Pharm. Mohammed, who was represented by Pharm. Oseni, urged the newly inducted pharmacists to abide by the ethics of the profession. He also advised them to develop leadership and interpersonal relationship skills, which he said were vital in Pharmacy practice.

The Registrar further encouraged the graduands to shun all manners of practices that will tarnish their image and by extension, the image of the Pharmacy profession.

The keynote speaker Pharm. Fagbemi,  an alumnus of the faculty, implored the graduands to hit the ground running, while emphasising the need for them to work hard and strive to be successful in whatever career they find themselves.

”As you begin life today as pharmacists with the end in mind, you must strive to achieve success in all areas of life, public, private and spiritual” she advised.

The high point of the event was the award of the much-coveted prize for the best graduating student, which was won by Basirat Oluwadamilola Rufai, with 6.9 CGPA, out of the total 7.0.

Meanwhile, 22 graduands came out with first class honours and were featured on the ‘Roll of Honour’, while Basirat Oluwadamilola Rufai, who graduated as the best overall student, won the highly coveted PCN prize, Faculty of Pharmacy Prize, UI Faculty of Pharmacy Alumni prize, Emeritus Professor Ajibola Olaniyi Prize, Professor Herbert Akinlolu Odelola Memorial Prize, and NAIP Prize. Also, Damilola Esther Olukorede, with CGPA of 6.8 out of 7.0 was the first runner up, as she bagged distinction in all the departmental courses.

 

 

520 New COVID-19 Infections, Five Deaths Reported Across 18 States, FCT

2

The Nigeria Centre for Disease Control has reported 520 new cases of COVID-19, bringing the total number of infected people in the country to 146,184.

The NCDC disclosed this figure on its official Twitter handle in the early hours of Monday.

The News Agency of Nigeria reported that with the 520 fresh cases in the last 24 hours, Nigeria recorded the lowest single-day rise in its tally in one week.

The health agency also registered five COVID-19 deaths due to complications from the virus, bringing the country’s total death toll to 1,752.

It stated that the new cases were reported in 18 states and the Federal Capital Territory.

NCDC said Ondo State registered 120 cases, Borno-41, Ebonyi-37, Benue-33, Plateau-30, FCT-29, Nasarawa-25, Ogun-25, Edo-24, Osun-24 and Katsina-22.

Kaduna, according to the agency, reported 21 new cases, Niger-20, Kwara-14, Ekiti-13, Yobe-10, Oyo had four, while Bayelsa and Jigawa had one each.

The NCDC noted that the data obtained from Borno and Ondo states were for the last two days.

It said about 439 people had been successfully treated for COVID-19 and were discharged on Sunday, raising the total number of recoveries in the country to 120,838.

The agency added that the discharged cases included 144 community recoveries in Rivers State.

It said that a multi-sectoral national Emergency Operations Centre, activated at Level 3 is coordinating response activities nationwide.

NAN reports that there are about 23,000 patients still receiving treatments in isolation centres, while nationwide, more than 1.3 million tests have been carried out since the index case was reported on February 27, 2020. 

(NAN)

UN Security Council to Debate Challenge of Global Vaccine Access

0

 

Covid-19: EU Secures Additional 300 Million Doses of Pfizer Vaccine
COVID-19 Vaccine

At the initiative of Britain, the UN Security Council on Wednesday will debate the problem of global access to COVID-19 vaccines, raising issues likely to underscore sharp differences between council members.

How, for example, can vaccines be distributed fairly – without, as has been the case, going first to the richest countries in the North while those in the South suffer?

Should blue-helmeted UN peacekeeping troops in some 15 countries, along with other UN employees deployed around the world, be declared essential workers and receive vaccine priority – including in countries yet to receive vaccine doses?

If so, who should provide the jabs – the United Nations, the troops’ countries of origin or those where they are deployed?

“Vaccine, vaccination is not the job of the Security Council,” said one ambassador, speaking on grounds of anonymity.

The Security Council, with a mission of maintaining peace and security around the world, has no special health expertise, the ambassador noted, adding, “the Security Council can just have a contribution.”

He added that no resolution on the matter is likely to come this week.

The Security Council’s only direct involvement in the pandemic came in July 2020 when, after long and difficult negotiations to resolve sharp US-Chinese tensions, it passed a resolution encouraging cease-fires in countries in conflict to limit the spread of COVID-19.

Britain recently shared with a few other countries a draft resolution on vaccine management, diplomats said.

“There is a draft resolution,” one said. “The negotiations have just started. It will take some time.”

Vaccination “is the big challenge now,” said Olof Skoog, the European Union ambassador to the council. “A long way to go before people are fully vaccinated.”

Skoog, who is Swedish, noted that the EU has contributed to creating the global Covax initiative which, under UN auspices, aims to provide at least two billion doses by the end of the year, including at least 1.3 billion doses to 92 lower-income countries.

“What we don’t want to see is a kind of vaccine apartheid,” with rich Northern countries receiving ample supplies and poorer Southern countries — as South Africa recently warned — going without, said the ambassador speaking anonymously.

He said negotiations over a Security Council resolution were likely to be “complicated,” with some countries uncomfortable at the “transparency” involved in committing themselves to leave no country wanting for the vaccine.

Several countries, including China, Russia and some Gulf nations, have already launched “vaccine diplomacy” initiatives, either showcasing their production capacity or providing easier access to vaccine doses.

UN Secretary-General Antonio Guterres has repeatedly sounded a warning that as the virus and its multiple variants spread around the world, global security can be assured only if everyone enjoys the same level of protection.

He has repeatedly called for vaccines to be treated as a “global public good,” without specifying exactly how that might happen.

Asked recently about the eventual UN role in establishing a sort of counterfeit-proof “vaccination certificate,” UN spokesman Stephane Dujarric said that “there needs to be international coordination and standardization of these things moving forward.”

Also of concern, he added, “is the criminal element of people falsifying vaccine certificates or, even worse, giving people false… vaccines that are not actual vaccines.

“So, I think the more international cooperation we can get on this, the better it is.”
(AFP)

 

ACPN, IDEA Zone gets New Executives

3

… Osinoiki, Adekola, charge them on good use of office

The Association of Community Pharmacists of Nigeria (ACPN), IDEA Zone has elected new crop of leaders to paddle the canoe of the association for the next three years. The election which was conducted during the Zonal Annual General Meeting, held at the Hob & Hog Event Centre, Shasha, Lagos, on Wednesday 10 February 2021, had notable pharmacists like National Chairman, ACPN, Dr Samuel Adekola; Former National Chairman, ACPN, Pharm. Deji Osinoiki; and  Immediate Past Zonal Coordinator, Pharm. Kola Sunmonu in attendance.

Addressing the new executives, Adekola, who conducted the oath of office on them urged them to hit the ground running, adding that the election has come and gone, and now is the time to settle down to work.

The number one community pharmacist in the country noted that ACPN, IDEA Zone holds a pivotal position to the practice of community pharmacy in Lagos state, and the country in general, adding that the commitment of the members of the zone at state and national events has made the zone a force to reckon with in the pharmaceutical political space.

L-R: Pharm, Mfon Nsese, former coordinator, IDEA Zone; Pharm. Kola Sunmonu, immediate past coordinator, IDEA Zone, and Pharm. Isaac Olufunminiyi, newly elected zonal coordinator, IDEA Zone, in a photograph shortly after the election.

Speaking in the same vein, Osinoiki, said the opportunity to work has presented itself to the new executives, stressing that it is a time to hit the ground running and to ensure that they move the Zone forward, while keeping to the vision and aspirations of the founding fathers.

He added: “Leadership position is a test of one’s ability, so I want you to keep the pace, don’t let the guard down, and ensure that IDEA zone remains the best in term of good pharmaceutical practice, as well as participation in the activities of our umbrella body, both at the state and national level”, he said.

In an interview with Pharmanews, the new Zonal Coordinator, Pharm. Isaac Olufunminiyi, who is a Merit Award winner of the PSN, Lagos State said the new executives would deliver their duties with vigour and carry every member along in running the affairs of the association, adding that they will keep the good name of the zone with higher ground to be conquered.

Speaking further, Olufunminiyi promised to bring his experiences to bare in discharging his duties, having held various positions in the past, such as former assistant secretary, PSN Lagos; inspector of Pharmacist Council of Nigeria (PCN); as well as deputy zonal coordinator of the zone, saying it is a call to serve.

“As the new zonal coordinator, I am aware it’s a huge responsibility on me and I am prepared for it. So, we will appoint a lot of young pharmacists into different committees, and we will mentor them as they are the future of the profession. We will encourage more group businesses to create trans-generational policies. We will make coming to meetings very interesting ones, and we will create a good atmosphere of love and more empathy among the members”, he assured.

While delivering a report on his stewardship to the AGM, Pharm. Sunmonu, the immediate past zonal coordinator beaming with smiles said he is full of gratitude for the love and support he enjoyed as the zonal coordinator for the past three years, saying it is obvious that a lot of waters have passed under the proverbial bridge of the zone, but the zone remains better than it was.

Speaking on their successes, he said the outgoing administration has built on the laudable foundation of the previous leadership of the zone, saying in spite of the many challenges posed by the lockdown occasioned by the outbreak of the COVID-19 pandemic, the zone was able to generate a list of illegal medicine sales outlets spanning across Mangoro, Cement, Onilekere, Isheri, Idimu, Dopemu, Oniwaya, Alfa-Nla, Iyana-Ipaja, Orile-Agege, Egbeda, Akowonjo, Shasha, Gowon Estate, Shagari Estate, Baruwa, Command, Ipaja and Ayobo areas of the zone.

He continued: “For a zone like ours that can boast of having some past national and state chairmen of ACPN, past national president of the PSN and several officers, both past and present across the pharmaceutical space, robust participation in all affairs relating to Pharmacy is highly important. This executive committee has exemplified this in every way; from the state ACPN Zonal Dynamics which we have won back-to-back in the last three years.

“The past year has witnessed record breaking supports and welfare packages to our members to the tune of five hundred and five thousand naira. This is excluding more than a quarter of a million donated on the floor of our monthly meetings as support for a member after a fire accident, and the over two million naira Insurance and welfare packages facilitated by the zonal executive committee from the state and national leadership of both the ACPN and the PSN”, he explained.

The highpoint of the event was the presentation of the new zonal executives, which are: Pharm. Isaac Olufunminiyi; Pharm. (Mrs) Emenike C. C, vice zonal coordinator; Pharm. (Mrs) Rebecca Akawa, secretary; Pharm. Kola Adeoluwa, assistant secretary; Pharm. (Mrs) Nkiruka Ibekwe, treasurer; Pharm. Nwankwo Chizoba, financial secretary; Pharm. (Mrs) Foluke Bamgbose, internal auditor, and Pharm. Sunmonu, as the immediate past zonal coordinator, to the leadership of the association.

Europe’s Oldest Person Turns 117 After Surviving Coronavirus

2

Sister Andre is the second-oldest living person in the world, according to the Gerontology Research Group, after Japanese woman Kane Tanaka, who is 118.

Europe’s oldest person, French nun Sister Andre, turns 117 on Thursday after surviving COVID-19 last month and living through two world wars, with a special birthday feast including her favourite dessert — Baked Alaska.

Sister Andre

Born Lucile Randon on February 11, 1904, Sister Andre said she didn’t realise she had caught the coronavirus, which infected 81 residents of her retirement home in the southeast city of Toulon, killing 10 of them.

“I’m told that I got it,” the nun told AFP ahead of her birthday. “I was very tired, it’s true, but I didn’t realise it.”

But David Tavella, spokesman for the Sainte-Catherine-Laboure nursing home, said she had “experienced a triple confinement: in her wheelchair, in her room and without a visit”.

“So her birthday, it reinvigorates us,” he added, following the deadly outbreak.

Sister Andre said she was not going to do anything special for her 117th birthday but the home is planning a celebration for her.

There will be a special mass at the home, which has a dozen nuns, and the chef is preparing a birthday feast of foie gras, capon fillet with porcini mushrooms and Sister Andre’s favourite dessert: baked Alaska, washed down with a glass of port.

She says her favourite food is lobster and she enjoys a glass of wine.

“I drink a small glass of wine every day,” she said.

Born in Ales in a Protestant family, she grew up as the only girl among three brothers.

One of her fondest memories was the return of two of her brothers at the end of World War I.

“It was rare, in families, there were usually two dead rather than two alive. They both came back,” she told AFP last year, on her 116th birthday.

She converted to Catholicism and was baptised at the age of 26. She joined the Daughters of Charity order of nuns at the relatively late age of 41.

Sister Andre was then assigned to a hospital in Vichy, where she worked for 31 years and then spent 30 years in a retirement home in the French Alps before moving to Toulon.

She is the second-oldest living person in the world, according to the Gerontology Research Group, after Japanese woman Kane Tanaka, who is 118.

Asked what she would say to young people, Sister Andre said: “Be brave and show compassion.”

AFP

 

 

Nigeria to Stick With AstraZeneca Coronavirus Vaccine Based on WHO Assessment

0

The National Primary Health Care Development Agency (NPHCDA) says Nigeria will stick with AstraZeneca vaccine based on its epidemiological and equity assessment done by the World Health Organisation (WHO).

The Executive Director, NPHCDA, Dr Faisal Shuaib, made the disclosure at the Presidential Task Force (PTF) on COVID-19 briefing on Monday in Abuja.

“As earlier communicated, Nigeria is no longer expecting the 100,000 doses of the Pfizer/BIONtech vaccine through the COVAX facility but has been allocated about 16 million doses of the AstraZeneca vaccine.

“This was based on epidemiological and equity assessment done by WHO.

“These vaccine will be arriving in batches, starting by late February,“ Shuaib said.

He noted that Nigeria was considered one of the countries ready to receive the Pfizer vaccine but, because the distribution intended to achieve public health value, it was not practical to provide every capable country with the vaccine due to its limited quantity.

“This necessitated further review by a multi-agency committee to narrow down the selection process.This information was disclosed to us by WHO.

“As stated by WHO regional director, a number of factors were considered in allocating the small quantity of 320,000 doses of the Pfizer vaccine to 13 countries in Africa.

“These include mortality rate from COVID-19, numbers of new cases, populations of the countries involved and availability of appropriate cold chain equipment,” he said.

According to the official, Nigeria is by no means ahead of countries such as South Africa in terms of mortality or incident rate of COVID-19, and is not the least populated in comparison to the other countries.

“Replacement of the initial 100,000 doses of the Pfizer vaccine with 16 million doses of the AstraZeneca vaccine is in fact a welcome development as it will enable a wider reach of our population and is a better option using our routine cold chain system, though we still have an ultracold chain capacity that would have been able to store more than 400,000 doses of the Pfizer vaccine,” he explained.

According to Shuaib, Nigeria has yet to find the South African variant of COVID-19 in its population, and will continue with plans to distribute the AstraZeneca vaccine.

He said that authorities were searching test samples for the South African strain and subjecting samples from travellers returning from the United Kingdom and South Africa to further genomic sequencing.

“We will continue to work with regulators to ensure that only a vaccine that is effective against the predominant COVID-19 strain in Nigeria will be administered.

“As you may be aware, South African Government has suspended vaccination with the Oxford/Astrazeneca vaccine in response to findings from a study which showed that the vaccine was less efficacious against the B.1.351 strain of the COVID-19 virus which is the predominant strain in South Africa.”

The executive director said that Nigeria had yet to isolate the strain.

“The Nigeria Centre for Disease Control, working with Nigeria Institute of Medical Research and others, will intensify search for this strain from samples collected.

“In the meantime, we will continue to work with NAFDAC to ensure that only a vaccine which is effective against the predominant COVID-19 strain in Nigeria will be administered,” he said.

He said that as part of ongoing awareness programme, the agency had met with the National Youth Council of Nigeria, and leadership of the Radio, Television and Theatre Art Workers Union.

He added that the agency would meet with over 50 more organisations and critical stakeholders to provide them with factual information that would enable them to produce educative content on the safety of COVID-19 vaccines.

He urged the mass media to present accurate and objective reports on that, and contribute to the fight against misinformation.

“The COVID-19 pandemic has, no doubts, posed a crisis amidst all other societal challenges.

“There is therefore no better time to be a patriotic citizen than now.

“I am confident that, working together as patriotic Nigerians, we shall collectively overcome the challenges,” Shuaib said.

He reassured Nigerians that the Federal Government was committed to acquiring sufficient COVID-19 vaccines which would safe, efficacious.

The News Agency of Nigeria (NAN) reports that Nigeria hopes to get 42 million doses of COVID-19 vaccine to cover one-fifth of its population through the global COVAX scheme.

The initial doses would come as part of Nigeria’s plan to inoculate 40 per cent of its population in 2021 and another 30 per cent in 2022 with 100,000 doses of the Pfizer vaccine.

The COVAX scheme was set up to provide vaccines to poorer countries such as Nigeria, with about 200 million people and infrastructure challenges

938 New COVID-19 Infections, 8 Deaths Recorded Across 19 States, FCT

0

The Nigeria Centre for Disease Control has reporded 938 new cases of COVID-19, bringing the total number of infections in the country to 143,516.

The NCDC disclosed this on its official Twitter handle early Friday morning.

The public health agency also confirmed additional eight coronavirus-related deaths in the last 24 hours, taking the total death toll to 1,710 in Nigeria.

The NCDC added that the fresh COVID-19 infections were reported from 19 states and the Federal Capital Territory.

It stated that Lagos State led with 236 new infections, followed by the FCT with 123 and Plateau 92.

Other states with new infections were Benue-63, Katsina-53, Oyo-50, Osun-45, Kaduna-43, Edo-33, Ogun-31, Ebonyi-31, Akwa Ibom-30, Kano-26, Gombe-18, Bauchi-16, Delta-12, Imo-11, Cross River-10, Rivers-10 and Niger, five.

The agency disclosed that more than 1,065 people had been successfully treated and were discharged on Thursday, raising the total number of recoveries to 118,012.

The NCDC noted that the discharged patients as of Thursday included 536 community recoveries in Lagos State, managed in line with set guidelines.

The NCDC said that a multi-sectoral national Emergency Operations Centre activated at Level 3 is coordinating response activities nationwide.

The News Agency of Nigeria reports that the country has so far tested 1,398,630 people since the first confirmed case of COVID-19 was recorded on February 27, 2020.

(NAN)

Antiallergic effect of glucocorticoids is caused by:

8

Antiallergic effect of glucocorticoids is caused by:

a) Suppression of leukocyte migration and stabilizing lysosomal membranes

b) Reverse the capillary permeability associated with histamine release

c) Suppression of the immune response by inhibiting antibody synthesis
d) All of the above

1,131 New COVID-19 Infections, 8 Deaths Reported in 21 States, FCT

1

The Nigeria Centre for Disease Control has announced 1,131 new cases of coronavirus, bringing the total number of infected people in the country to 142,578.

The NCDC disclosed this on its official Twitter handle early Thursday morning.

The health agency said that in the last 24 hours, 1,131 people tested positive in 21 states and the Federal Capital Territory.

It confirmed eight coronavirus-related deaths also in 24 hours, bringing the country’s COVID-19-related deaths to 1,702.

The NCDC stated that the registered infections showed that Lagos State recorded the highest number with 297 new infections, taking the total number of cases in the nation’s commercial hub to 52,282.

It said the FCT came second with 194 new infections, upping the cumulative cases in the nation’s capital to 18,168.

Kaduna State had 83 new cases; Kano 59; Oyo 58; Taraba 53; Imo 52; Osun 47; Plateau 45 and Edo 43 cases.

Others were Akwa Ibom and Rivers 42 cases each; Ogun-29; Kwara-24; Benue-21; Nasarawa-16; Ekiti-7; Bauchi and Delta 6 each; Bayelsa-4; Sokoto-2 and Gombe-1.

The NCDC said that more than 1,192 people had been successfully treated and discharged on Wednesday, raising the total number of recoveries in the country to 116,947.

It stated that discharged cases, as of Wednesday, included 773 community recoveries in Lagos State and 66 community recoveries in Imo, all managed in line with stipulated guidelines.

The NCDC said that a multi-sectoral national Emergency Operations Centre, activated at Level 3, is coordinating response activities nationwide.

The News Agency of Nigeria  reports that in Week Five, the number of new confirmed cases decreased to 8,506 from 9,676 reported in Week Four in 35 states and the FCT.

In Week Five, the country’s number of discharged cases increased to 8,536 from 7,761 in Week Four, reported in 32 states and the FCT.

The number of reported deaths in the last one week in 15 states and FCT was 81 and the cumulative deaths since the outbreak in February 2020 were 1,667 deaths, with a Case Fatality Rate of 1.2 per cent.

Also in Week Five, the number of in-bound international travellers at Nigerian airports was 14,507, compared with 15,156 in Week Four.

In Week Five, the number of international travellers, who tested positive to the virus, was 155 compared with 471 in Week Four.

Globally, more than 105 million people have been infected with the virus ,with 2,302,302 deaths, resulting in a CFR of 2.2 per cent.

(NAN)

Basirat Rufai Emerges Best Graduand of UI Pharmacy Faculty

1
UI Pharmacy Faculty Produces Overall Best Graduand for 2018/2019 Session
Basirat Rufai

Pharmacy Faculty, of the University of Ibadan (UI) has done the Pharmacy profession proud by producing the best Pharmacy graduand in the person of Basirat Rufai with a CGPA of 6.9 over 7.0, for the 2018/2019 academic session.

Rufai, a first-class graduate of Pharmacy, cleared all her courses with distinctions to emerge the overall best graduating student in the College of Medicine, UI.

The brainy lady, whose joy knows no bound at the moment attributed the feat to divine support and that of her parents, lecturers and loved ones.

In her recent post on her LinkedIn profile, the brainy lady specially acknowledged God’s grace in her successful academic journey, saying “It is only by God’s grace”.

“Special appreciation goes to the Almighty God for His unending support. Also, my parents, family, lecturers, classmates and friends who assisted me in this journey. “I must say I am proud of myself baby girl” she enthused.

For her excellent academic performance, she has won some awards to her merit, including Pharmacists Council of Nigeria Best Graduating Pharmacy Student Award; Faculty of Pharmacy, University of Ibadan, Overall Best Graduating Student Award for 2018/2019 Session, and others.

 

 

Which drug inhibit enzymes?

10

This drug both inhibits an enzyme and indirectly enhances clearance of low density lipoproteins (LDL):

a) Cholestyramine (Questran)

b) Lovastatin (Mevacor)

c) Nicotinic acid (niacin)

d) Probucol (Lorelco)

What You Should Know About Ovulation – Medical Expert

0

A medical expert, Dr Julieet McGrattan, says women generally encounter different kinds of pain every month, from their periods to appendicitis and for some stomach ulcer. However, if this occurs every month in the middle of menstrual cycle, then there is a need to suspect ovulation pain.

McGrattan, in her recent interview published on yahoo.com said most women are unaware when one of their ovaries releases an egg. It happens painlessly, as part of a normal menstrual cycle. However some women may experience discomfort and even severe pain during this time.

What You Should Know About Ovulation – Medical Expert
A woman having issues with her tummy

Although, ovulation pain is harmless, she said it’s worth knowing what else might be causing your lower abdominal pain, so you know when to take action and what you can do to ease the pain. The coach and author explains ovulation pain, causes, symptoms and treatment options:

What is Ovulation?

Every month, one of your ovaries releases a mature egg, which then travels down the fallopian tube. If it meets sperm, it becomes fertilized and travels to your uterus, where it implants itself in the uterine lining which has thickened for this purpose. If the egg isn’t fertilized, the uterine lining and the egg are shed, causing you to get your period.

Why ovulation pain?

She noted that no scientist have been able to come up with the reason why ovulation cause pain and why women experience discomfort in the middle of their menstrual cycle, however, there is a theory that when the egg bursts out of the follicle it was growing in, there may be a small amount of fluid or blood released that irritates surrounding tissues and nerves.

What does ovulation pain feel like?

Every woman is different but here are some key facts about ovulation pain:

  • Ovulation pain is usually a sharp pain.
  • Sometimes ovulation pain is a dull cramp.
  • The pain is usually in the lower abdomen and concentrated on one side.
  • Ovulation pain may be on the right or the left, according to which ovary has released an egg.
  • Sometimes the pain can spread more generally across the lower abdomen.
  • Ovulation pain tends to come on fairly quickly and can last from a few minutes to one or two days.
  • Ovulation pain might be very mild or it may feel extremely painful.
  • Ovulation pain can hurt when you move around, press on the sore area, cough or jump.
  • Mild backache is not uncommon with ovulation pain.

You might notice other changes in your body that go along with ovulation such as an increase in the amount and consistency of your vaginal discharge. If it becomes more slippery and resembles egg-white, then this is a sign that ovulation may have occurred.

You may also have a small amount of vaginal bleeding called ‘spotting’ around ovulation too.

When do you get ovulation pain?

Ovulation pain usually happens in the middle of the menstrual cycle. In fact, it is also known as mittelschmerz which is the German word for ‘middle pain’.

The menstrual cycle is controlled by a range of female hormones including oestrogen and progesterone. Day 1 of your menstrual cycle is when your period bleeding starts. At this point oestrogen and progesterone levels are both quite low. Over the next couple of weeks, the oestrogen level rises as your ovaries get ready to release an egg. The rising oestrogen triggers a surge in a hormone called luteinising hormone (LH) which sparks ovulation. This happens around day 14 in a woman with a 28-day menstrual cycle.

Not all women have a 28-day cycle and ovulate on day 14. It can vary from month to month and woman to woman. Some women have a shorter or longer cycle. Some women don’t ovulate in every cycle, such as those who have polycystic ovary syndrome. If you want to know when you ovulated, then a better calculation is 14 days before your period rather than 14 days after it began.

Who gets ovulation pain?

Any menstruating woman can have pain when an egg is released from the ovary. This may happen every month, every now and then or as a one-off.

Not all women get pain from ovulation. The majority of women are unaware they have ovulated or any discomfort they feel is minor and goes unnoticed or is attributed to something else such as wind or a twinge from a muscle.

You are more likely to get ovulation pain if you have any scarring of the tissues around the ovaries and fallopian tubes. Scarring, also called ‘adhesions’ can happen as a result of a sexually transmitted infection such as chlamydia or as a result of surgery to the womb, ovaries or bowel. Ovulation pain is also more common in women who have endometriosis because the ovaries and fallopian tubes can be inflamed and sensitive.

If you are in acute or worsening pain don’t try to self-diagnose any of the above, make an urgent appointment with your doctor if you are concerned.

How is ovulation pain diagnosed?

Thankfully, ovulation pain isn’t usually severe. It’s most commonly a niggly pain that doesn’t last long enough and isn’t severe enough for you to be concerned enough to see a doctor. Looking at the timing of the pain in relation to your menstrual cycle is the key to diagnosing it. You’ll realise that each time it happens it’s a couple of weeks before your period.

If you are tracking your menstrual cycle for fertility reasons and trying to spot ovulation by measuring your temperature, checking your vaginal discharge or using an ovulation kit, then it will be easy to link the pain to your mid-cycle.

Occasionally ovulation pain can be severe and you may end up seeing a doctor as an emergency worrying that something else is going on. The doctor will ask you lots of questions and examine you to work out the cause of the pain. Unless it is impossible for you to be pregnant they will do a pregnancy test to rule out an ectopic pregnancy. This is unlikely if you haven’t missed a period but because an undiagnosed ectopic pregnancy (where the foetus grows in the fallopian tubes) can be life threatening to the mother, they will need to exclude it.

If you have severe abdominal pain, you should be assessed by a doctor. Sometimes admission to hospital is needed for further urgent investigations such as blood tests and scans to look for ovarian cysts or appendicitis.

How is ovulation pain treated?

There are a few things you can do if you have ovulation pain:

Get plenty of rest: Ovulation pain can sometimes make it hurt to walk around so take things easy.

Distract yourself: Pain is always worse when you focus on it so do things to keep your mind off it.

Use heat: A hot water bottle or a warm pack held on your lower tummy can ease ovulation pain and so can a nice warm bath.

Try paracetamol: Paracetamol is a good first step. If this isn’t giving you any relief after two hours then try ibuprofen, check with your pharmacist to make sure it is safe for you to take.

 

NAPharm Partners NGE, Inaugurates COVID-19 Special Committee

0

 

Encomiums as Prince Julius Adelusi-Adeluyi Clocks 79
Prince Julius Adelusi-Adeluyi

For the first time since its establishment in 2014, the Nigeria Academy of Pharmacy (NAPharm) has entered into a partnership with a non-health sector group- the Nigerian Guild of Editors (NGE) towards the creation of awareness around the COVID-19 pandemic as well as demystifying various conspiracy theories surrounding the infection.

The coalition, in a virtual event held on Tuesday inaugurated the Special COVID-19 Committee with Pharm. (Sir) Ifeanyi Atueyi, Pharmanews Publisher, as chairman; Mr Azubuike Ishiekwene, MD/Editor-In-Chief of The Interview Magazine, as co-chairman and Mary Atolagbe, publicity secretary. Others are Chima Ogbu, secretary; Busayo Abolarin, assistant secretary and Dr Lolu Ojo, director of programmes.

In his keynote address, NAPharm. President, Prince Julius Adelusi-Adeluyi, stressed the need for collaboration in the fight against the pandemic as a particular group may not have all it takes to create the necessary impact in the war against COVID-19.

He emphasised pharmacists’ roles in the pandemic but explained that these functions could be better enhanced through a partnership for proper penetration of the society and breaking of new grounds.

 “This is the first time that a non-health sector group has been chosen as partners to underscore the need to create awareness around the COVID-19 pandemic.

“We strongly believe that much more can be achieved together if we pool resources together in such a way that we amplify the good and debunk the bad.

“Pharmacists’ have a role to play and have to be seen as playing that role, and one way to penetrate the public is to bring in the media.

 “COVID-19 is a crisis and we have been exposed to it, but we must not let the opportunity waste away because this is our chance to break new grounds.

“We need to tackle the issues; that COVID-19 is real and that it is propelling the fear factor among a section of the population,” he said.

Sir Atueyi, vice-president, NAPharm had earlier welcomed participants to the inauguration which was attended by pharmaceutical professionals, researchers, academia and members of the Nigerian Guild of Editors.

He explained the rationale behind the inauguration of the academy’s COVID-19 Special Committee which was to assist the Federal Government’s efforts at curtailing the spread of the pandemic.

Atueyi chronicled the activities of the academy from inception on 26 June 2014 till date with 47 members to 82 members presently, as it has facilitated various reforms in the tertiary institutions, hosted a pharmacy education summit, provided mentoring and guidance to young pharmacists through various programmes, recognised notable Nigerian leaders who have made meaningful contributions in the country, fostering inter-professional collaboration among Nigeria’s healthcare professionals, among others.

“Since it was founded on June 26, 2014, NAPHARM has contributed to efforts leading to some milestones in the overall health delivery value chain in Nigeria.

“We started with 47 members and now we have 82 members of the academy.In those years, we have facilitated reforms in the tertiary institutions, hosted a pharmacy education summit and provided mentoring and guidance to young pharmacists through various programmes,” he said.

In his own contribution, the President, Nigerian Guild of Editors, Isah Mustapha, commended NAPharm for taking a collaborative approach to its COVID-19 response mechanism.

 

Pharmaceutical Marketing: Basic Concepts and Principles

1

Marketing is a general term used to describe all the various activities involved in transferring goods and services from producers to consumers. Though commonly associated with advertising and sales promotion activities, marketing also encompasses product development, packaging, distribution channels, pricing and many other functions.

Management guru, Peter F. Drucker, claimed that marketing “is so basic it cannot be considered a separate function. … It is the whole business seen from the point of view of its final result, that is, from the customer’s point of view.” Marketing is the source of many important new ideas in management thought and practice – such as flexible manufacturing systems, flat organisational structures and an increased emphasis on service – all of which are designed to make businesses more responsive to customers’ needs and preferences.

Marketing, mainly an American creation, is focused on Fast Moving Consumer Goods (FMCGs). However, the ideas and concepts can be, and have been applied and adapted for industrial and technical products like medicines, services, automobile, aviation, politics, etc. Pharmaceutical marketing, as a discipline increased strongly in the second decade following the Second World War, during which time thousands of new molecules entered the market, and thus “overwhelming” physicians with new scientific facts to learn in order to safely and appropriately prescribe these breakthroughs to their patients. There was a great dependence on the pharmaceutical companies’ marketing departments and their professional sales representatives to give the full information necessary to support the prescribing decision.
The marketing of medicines continued to grow strongly throughout the 1970s and 1980s. The size of pharmaceutical sales forces increased dramatically during the 1990s, as major pharmaceutical companies, seeing as a competitive necessity, sales forces were increased to match or top the therapeutic competitor, increasing frequency of visits to physicians and widening coverage to all potential customers. Marketing techniques, perceived as “excessive” and “extravagant”, resulted in regulation of pharma marketing activities and strategies in most develop countries.

Pharma marketing essentials
What are the basic concepts of marketing, especially as it applies to pharmaceutical marketing? Before we go into this, it will be necessary to compare and contrast drugs and FMCG

What exactly is marketing in itself? Marketing is a “societal process by which individuals and groups obtain what they need and want through creating, offering and freely exchanging products and services of value with others”. This is a definition from the point of view of the society. Marketing professionals will define it as “the process of planning and executing the conception, pricing, promotion and distribution of ideas, goods and services to create exchanges that satisfy individual and organisational goals.”

In essence, marketing is intended to focus all of a company’s activities to discover and satisfy customers’ needs. Pharmaceutical marketing can be thus defined as a management process that serves to identify and meet healthcare practitioners’ and patients’ needs in a profitable way. Pharmaceutical marketing may also be considered as activities focused on making physicians (and other HCPs) as well as the general public aware of new and existing pharmaceutical brands chose the specific offering against other or similar products.

Let’s proceed to examine some marketing concepts, mostly as applied to FMCGs before we delve into its modification and adaptation for pharmaceutical marketing.

Need: This is considered a state of deprivation or lack or absence felt or observed by human beings. It may be physical (as in food, clothing, warmth, safety), or social (lack of sense of belonging and affection), or individual ideal or idea (knowledge and self-expression/self-actualisation). It must be stated here that marketers do not create basic needs. They are there naturally and serve as a necessity for our biological and social existence well-being.

Wants: These are the exact form that our needs take in the process of fulfilling them. They are driven by many factors including culture, individual personality, socio-economic status, education, family and aspirational groups. We need food, but may want garri (in water), Chinese rice, spaghetti, Ofada rice, or delicacies from an eatery. Our need may be mobility, but what we want to execute this need for mobility can take the form of a Raleigh bicycle, a Honda motor bike, or cars like Kia Picanto, Toyota Corolla, Nissan Jeep, or a Mercedes-Benz Bullet Proof 2020 G-Wagon! All these serve the basic function of moving around but come with different specifications, in terms of functionality, lifestyle, safety, status, emotional attachment, etc.

A marketer may exert enormous influence on our choice at this point using communication and marketing tools and strategies. They are even ascribed with even power to create a want from nothing!
Demands: These are wants backed by buying power. This is the same elementary definition of effective demand as taught in secondary school economics class. No matter how a person wants your product, if he doesn’t have the money to pay for it, he is not in your target audience!
Customer value and satisfaction expectations: Value is considered to be the most exact measure of satisfaction. How much are you willing to pay (in terms of money, effort, waiting, opportunity cost, etc.) for Product A as against a functionally similar product B? This is the equivalent value of satisfaction you believe you will derive from that product, i.e., utility value to you. The table below explains the role of marketers in setting value and making commensurate expectation promises for their brand:

Exchange and transaction: Exchange is the act of obtaining a desired object from someone by offering something in return. It implies at least two people must be involved, they must be willing to do business with each other and each with things of respective value Transaction is trading between two parties that involves at least two things of value, agreed-upon conditions, a time of agreement, and a place of agreement. On one hand, such activity may be without significant involvement with each other or with a lot of involvement with each other on the other hand. The latter part is the basis for relationship marketing, with a view towards long-term and mutual benefits.

Market: Markets are the actual and potential buyers of a product. At this point of our civilization, it really no more a physical space where everyone is present. More than ever, it is becoming more and more virtual! (To be continued)

Global COVID-19 Cases Near 107m as Deaths Top 2.3m

0

The novel coronavirus has killed at least 2,325,744 people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP at 1100 GMT on Tuesday.

At least 106,407,000 cases of coronavirus have been registered. Of these, at least 64,934,600 are now considered recovered.

These figures are based on daily tolls provided by health authorities in each country and exclude later re-evaluations by statistical organisations, as has happened in Russia, Spain and Britain.

On Monday, 8,586 new deaths and 338,210 new cases were recorded worldwide.

Based on the latest reports, the countries with the highest figures for new deaths were the United States with 1,492 new deaths, followed by Spain with 909 and Brazil with 636.

The United States remains the worst-affected country with 465,083 deaths from 27,097,346 cases.

After the US, the hardest-hit countries are Brazil with 232,170 deaths from 9,548,079 cases, Mexico with 166,731 deaths from 1,936,013 cases, India with 155,158 deaths from 10,847,304 cases, and the United Kingdom with 112,798 deaths from 3,959,784 cases.

The country with the highest number of deaths compared to its population is Belgium with 185 fatalities per 100,000 inhabitants, followed by Slovenia with 175, the United Kingdom 166, the Czech Republic 163 and Italy 151.

Europe overall has 777,558 deaths from 34,705,603 cases, Latin America and the Caribbean 621,002 deaths from 19,624,793 infections, and the United States and Canada 485,902 deaths from 27,903,793 cases.

Asia has reported 245,184 deaths from 15,513,247 cases, the Middle East 99,620 deaths from 4,946,247 cases, Africa 95,533 deaths from 3,681,519 cases, and Oceania 945 deaths from 31,804 cases.

Since the start of the pandemic, the number of tests conducted has greatly increased while testing and reporting techniques have improved, leading to a rise in reported cases.

However, the number of diagnosed infections is only a fraction of the real total because a significant number of less serious or asymptomatic cases go undetected.

As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day’s tallies.

(AFP)

WHO Fails to Find Animal Source of COVID-19

0

The WHO mission to China to uncover the origins of the coronavirus has failed to identify the animal source, scientists said on Tuesday.

Experts believe the disease – which has gone on to kill more than 2.3 million people worldwide – originated in bats and could have been transmitted to humans via another mammal.

While transmission from animals was the likely route, so far “the reservoir hosts remain to be identified”, Liang Wannian, head of the China team, told reporters.

He added that studies showed the virus “can be carried long-distance on cold chain products,” appearing to nudge towards the possible importation of the virus — a theory that has abounded in China in recent months.

He also said there was “no indication” the sickness was in circulation in Wuhan before December 2019 when the first official cases have been recorded.

WHO foreign expert Ben Embarak, who was based in the WHO’s Beijing office for two years from 2009, backed up the assertion saying there was no evidence of “large outbreaks in Wuhan” before then.

The mission is a diplomatically knotty one, which was trailed before it began by fears of a whitewash, with the US demanding a “robust” probe and China firing back with a warning not to “politicise” the investigation.

During the closely-monitored visit, reporters were largely kept at arms’ length from the experts, but snippets of their findings crept out over Twitter and interviews.

The experts spent one month in China, two weeks in quarantine and the same again on fieldwork.

But, already over a year after the virus emerged, some of it was of questionable relevance to their stated aim of finding the virus source, including a visit to a propaganda exhibition celebrating China’s recovery from the pandemic.

The group spent just an hour at the seafood market where many of the first reported clusters of infections emerged over a year ago.

They also appeared to spend several days inside their hotel, receiving visits from various Chinese officials without going out into the city.

But deeper research was carried out at the Wuhan virology institute where they spent nearly four hours and said they met with Chinese scientists there including Shi Zhengli, one of China’s leading experts on bat coronaviruses and deputy director of the Wuhan lab.

Former US Presiden,t Donald Trump repeated a controversial theory that a laboratory leak may have been the source of the pandemic.

Scientists at the laboratory conduct research on some of the world’s most dangerous diseases, including strains of bat coronaviruses similar to COVID-19.

Beijing is desperate to defang criticism of its handling of the chaotic early stages of the outbreak.

It has refocused attention at home – and abroad – on its handling of and recovery from the outbreak.

(AFP)

How to Know The Difference Between Types of Diabetes

0

A professor of Medicine and endocrinologist at the Lagos State University Teaching Hospital and associate professor of Medicine at Vanderbilt University in Nashville, Antonia Ogbera, has recently shed more light on the difference between type 1 and type 2 diabetes.

Prof. Ogbera said diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia. In the oral cavity, diabetes mellitus may lead to salivary dysfunction,increased susceptibility of oral tissues to trauma and periodontal disease.

She explained the major types of this disease, which are type 1 diabetes mellitus and type 2 diabetes.The type 1 has its onset in childhood and requiring lifelong insulin injections,while the type 2 has its onset in adulthood and often requiring glucose lowering drugs (in tablet form) and sometimes insulin injections.

The endocrinologist noted that type 2 diabetes mellitus is the commonly occurring type of diabetes mellitus and it accounts for 95 per cent persons of persons living with diabetes mellitus.

“The type 2 diabetes mellitus is a global public health crisis that threatens the economies of all nations, particularly developing countries including Nigeria”.

“Although type 2 diabetes mellitus has its onset in adults usually above 30 years of age, this form is becoming increasingly common in teenagers and the reasons for this scenario include, intake of calorie dense foods, lack of exercise and overweight or obesity, she said”.

Dr Michelle Griffith, a practicing endocrinologist, also gave signs and symptoms of diabetes that are common to both types of diabetes.

Fatigue; hunger during or shortly after a meal; weight loss; despite eating more; extreme thirst; frequent urination, blurred vision; slow healing of cuts and bruises; tingling; pain; or numbness in the hands or feet; and acanthosis nigricans; an issue that causes skin on the neck; armpits; groin; and other areas to change colour and texture, possibly becoming velvety

It is worth noting that factors such as age and overall health can affect how a person experiences these symptoms.

Diagnosis and treatment

Griffith said: “Doctors are the ones that typically diagnose diabetes by asking about symptoms and ordering a blood test, which can show high blood sugar levels.

She said if the person is not experiencing symptoms, the doctor may order a follow-up test to confirm the diagnosis.

“Treatment depends on the type of diabetes. A person with type 1 needs to take insulin every day, using injections or pumps.

“For a person with type 2 diabetes, a doctor recommends self-care strategies and other ways to manage blood sugar levels. This might involve taking prescribed medications, including insulin, she added.”

Dr Griffith advised that it is important to follow the recommended treatment plan. Anyone who is having difficulty doing this or experiencing any side effects should consult their doctor for guidance right away.

According to Medicalnewstoday, type 1 diabetes develops when the body’s immune system attacks the cells in the pancreas that are responsible for producing insulin.

It added that when this happens, the body cannot produce enough insulin to process and regulate blood sugar and as a result, people with type 1 diabetes require lifelong insulin in addition to other therapies and care strategies.

Health experts are still unsure of the precise causes, but genetic and environmental factors, such as viruses, may play a role.

It also noted that a person with type 2 diabetes either does not produce enough insulin or their body does not use it efficiently. The latter is known as insulin resistance. According to the site, a person with type 2 has excess sugar builds up in the bloodstream, resulting in symptoms and, without treatment, complications.

Type 2 diabetes typically develops in older adults, but it can affect younger people.

Also, type 2 diabetes appears to be more common among people who:

have obesity

have overweight

are not physically active or have a sedentary lifestyle

have extra belly fat

have had gestational diabetes, which develops during pregnancy

have hypertension, or high blood pressure

are older than 35

have a family history

According to American Diabetes Association, these are the healthy foods any diabetic person should eat: Fruits and vegetables, lean meats and plant-based sources of protein, less added sugar and less processed foods.

Health facts: About diabetes

About one third of people with diabetes do not know they have the disease.

Type 2 diabetes often does not have any symptoms.

Only about five per cent of people with diabetes have type 1 diabetes.

If you are at risk, type 2 diabetes can be prevented with moderate weight loss (10–15 pounds) and 30 minutes of moderate physical activity (such as brisk walking) each day.

A meal plan for a person with diabetes isn’t very different than that which is recommended for people without diabetes.

Diabetes is the leading cause of blindness in working-age adults.

People with diabetes are twice as likely to develop heart disease as someone without diabetes.

Good control of diabetes significantly reduces the risk of developing complications and prevents complications from getting worse.

Bariatric surgery can reduce the symptoms of diabetes in obese people.

Diabetes costs $174 billion annually, including $116 billion in direct medical expenses.

Spotting the early symptoms of diabetes can help a person receive a timely diagnosis and start treatment right away. This helps prevent diabetes complications, which can be very dangerous.

 

 

 

 

The mechanism of fluoxetine action includes:

20

The mechanism of fluoxetine action includes:

a) Selective inhibition of serotonine uptake in the CNS

b) Little effect on central norepinephrine or dopamine function

c) Minimal binding to cholinergic, histaminic, and alfa-adrenergic receptors

d) All of the above

NAFDAC Seals Food Factory for Revalidating Expired Spices

0
NAFDAC Seals Food Factory for Revalidating Expired Spices
Fake curry being revalidated and repackaged by SomGeo staff

For endangering public health through the revalidation of expired Curry and Thymes spices, the National Agency for Food and Drug Administration and Control, NAFDAC, has shut down, Every Rose Limited, manufacturers of SomGeo brand of spices.

Officials of the agency who visited the factory unannounced, discovered large quantities of expired Curry and Thyme spices stored in the warehouse with packaging materials, labels as well as stamps that were being used to illegally revalidate the already expired spices, NAFDAC revealed.

This is coming barely eight weeks after NAFDAC shutdown six pharmaceutical companies for their failure to comply with Good Manufacturing Practice standard in the country. Although names of the concerned companies were not disclosed by the agency, but they have been placed under close surveillance by the regulatory body.

Speaking on the development, the Director General, NAFDAC, Prof. Moji Adeyeye frown at the act saying the company will be heavily sanctioned for jeopardizing the health of Nigerians.

Prof. Adeyeye who spoke through a statement signed by Resident Media Consultant to NAFDAC, Sayo Akintola, said immediately officials of the agency got tip-off of the development, they swooped on the main warehouse and factory of Every Rose Limited manufacturers of SomGeo brand of spices located at Petu Village, Cele 2, Bus Stop Off Ibeju-Lekki, and No. 23, Tunji Lekki,Bello Street, Penuncular Stream 2, Lekki, Lagos respectively.

She stated that the two locations visited were sealed and placed on hold, adding that the company staff found revalidating the aforementioned products at the factory have been apprehended and taken to NAFDAC Investigation & Enforcement office for further investigation.

While the business owner, a lady, (names withheld) was at large during the raid, Adeyeye revealed that different finished products and working tools were found.

Records available in NAFDAC show that the company located at 19, Adelajo Ojo Crescent, Magodo, Lagos, registered 16 different products for listing under the brand name SOMGEO and these include SOMGEO Ginger Powder, SOMGEO Garlic Powder, SOMGEO Thyme Leaves and SOMGEO Mixed Spices Powder amongst others. The registration however, expired on December 5, 2017.

Citing this case as an example to others in such illegal businesses, the NAFDAC boss warned that there is no more hiding place for unscrupulous manufacturers and marketers who have turned themselves to merchants of death with a view to making illicit money by sending unsuspecting Nigerian consumers to their early graves through production and sale of falsified and revalidated expired products.

She said the agency would stop at nothing to track down the illicit merchants wherever they are within the country.

‘’We are ready to eliminate the incidence of falsified products in our markets or bring it down to the minimum to safeguard the health of our people’’, she said.

 

Serotonin Syndrome is a Result of:

7

Serotonin syndrome is a result of:

a) Increased stores of monoamine

b) Significant accumulation of amine neurotransmitters in the synapses

c) Both a and b

d) Depleted stores of biogenic amines

Having a Happy Childhood Does Not Assure Good Mental Health – Research

1

Contrary to the believe that only difficult childhood can increase the likelihood of mental illness, a new research from University of South Australia in partnership with the University of Canberra has shown that a sweet and happy childhood does not always protect a child from suffering mental health problems later in life.

The study published in Current Psychology examined how early childhood experiences relate to different developmental pathways, and how these might be associated with poor mental health.

Image of a very beautiful child

Lead researcher, Bianca Kahl, believes the study highlights the fact that mental illness is not limited to negative experiences of childhood alone.

“As the number of mental health conditions expands, it’s imperative that we also extend our knowledge of this very complex and varied condition,” Kahl explained

“This research shows that mental health conditions are not solely determined by early life events, and that a child who is raised in a happy home, could still grow up to have a mental health disorder.”

The researchers examined how various childhood experiences could relate to different developmental pathways and how this may in turn impact mental health.

Though the study reassures the belief that children who experience adverse and unpredictable early life experiences could suffer elevated symptoms of poor mental health, including depression, results also suggested that kids who grew up in stable and supportive environments were also at risk of experiencing symptoms of anxiety in adulthood.

Kahl believes the research could help identify other key insights about potential mental health risk factors for all children.

“There’s certainly some missing factors in understanding how our childhood environment and early life experiences might translate into mental health outcomes in adulthood,” she explains.

“We suspect that it’s our expectations about our environments and our ability to adapt to scenarios when our expectations are not being met, that may be influencing our experiences of distress.

“If, as children, we learn how to adapt to change, and we learn how to cope when things do not go our way, we may be in a better position to respond to stress and other risk factors for poor mental health.”

Kahl added that it is the testing of this hypothesis that will form the focus of her next research study.

The new research follows a previous study which suggested children who are smacked at a young age are more likely to suffer from poor mental health and have behavioural problems through to their teenage years.

Those who experienced “adverse childhood experiences” (ACEs), such as smacking and harsh parenting, had poorer outcomes than those who did not, the study led by UCL researchers revealed.

The study, published in the journal Child, Abuse and Neglect, builds on previous evidence by University College London (UCL), which led to the smacking ban in Scotland last year.

Researchers say this new study added more weight to calls to provide children in England with legal protection from smacking and physical punishment.

A further study also suggested that telling children lies, even with the best intentions, could have an impact on their mental health later in life.

While parents telling lies to their children intending to encourage good behaviour may seem harmless enough, according to a study, by China’s Xinyang Normal University, it could lead to them feeling more anxious in adolescence.

Researchers suggested telling children narratives such as ‘eating carrots will help you see in the dark’ could increase their risk of suffering from anxiety in later life and can also impact teenagers’ relationships with their parents.

 

 

Ebola Strikes Again In DR Congo

3

A new positive case of Ebola virus disease has been confirmed in North Kivu, a province in eastern Democratic Republic of Congo (DRC).

Minister of Public Health Eteni Longondo disclosed this on Congolese national television (RTNC) Sunday.

The victim is a woman farmer and wife of a survivor of the recent Ebola virus disease in the Butembo health zone, located in North Kivu.

She first showed the symptoms of the disease on Feb. 1, said the official.

The samples taken from the body of the victim were sent to the laboratory of the National Institute of Biomedical Research (INRB) in Kinshasa and were found to be positive for Ebola virus disease, according to the official.

He also confirmed the activation of the on-site response team in Butembo to trace the victim’s contacts.

The DRC announced on Nov. 18, 2020 the end of the 11th epidemic which hit the same part of the country hard.

Concerns Grow Over AstraZeneca Vaccine

0

South Africa suspended the start of its AstraZeneca inoculation programme over concerns the shot does not work on a new variant, with WHO experts due to meet Monday to discuss the vaccine already facing questions about its efficacy for over-65s.

A trial showed the vaccine provides only “minimal” protection against mild to moderate Covid-19 caused by the variant first detected in South Africa, a setback to the global fight against the pandemic as many poorer nations are relying on the logistical advantages offered by the AstraZeneca shot.

Africa’s hardest-hit nation was due to start its campaign in the coming days with a million AstraZeneca doses but the government decided to hold off in light of the results from the trial conducted by the University of Witwatersrand in Johannesburg.AstraZeneca Says its Vaccine Needs ‘Additional Study’

“It’s a temporary issue that we have to hold on AstraZeneca until we figure out these issues,” Health Minister Zweli Mkhize told reporters on Sunday.

The 1.5 million AstraZeneca vaccines obtained by South Africa, which will expire in April, will be kept until scientists give clear indications on their use, he added.

AstraZeneca, which developed the shot with the University of Oxford, told AFP: “We do believe our vaccine will still protect against severe disease.”

A company spokesperson said researchers were already working to update the vaccine to deal with the South African variant, which has been spreading rapidly around the world.

A World Health Organization panel is due to meet on Monday in Geneva to examine the shot, which is a major component of the initial Covax global vaccine rollout that covers some 145 countries — mostly lower- and lower-middle income economies.

Out of the initial 337.2 million Covax doses, 240 million are AstraZeneca shots, which do not require the super cold storage needed for the Pfizer and Moderna vaccines.

There were already concerns about the efficacy of the AstraZeneca shot among over-65s, with a number of European nations not authorising it yet for that demographic.

‘Be careful’ 
The coronavirus pandemic has claimed more than 2.3 million lives globally out of nearly 106 million known infections, and despite the AstraZeneca setback, vaccine rollouts in other countries are gathering pace.

Hungarian authorities said Sunday they have approved Russia’s Sputnik V shot, while Cambodia became the latest nation to receive delivery of the Chinese Sinopharm vaccine, taking on 600,000 doses of the jab.

Efforts are under way in the United States, the hardest-hit nation, to accelerate its mass vaccination programme, which has been plagued by supply and logistics issues.

President Joe Biden, who took office last month, said his predecessor Donald Trump’s handling of the pandemic “was even more dire than we thought”.

“We thought they had indicated there was a lot more vaccine available, and it didn’t turn out to be the case,” he told CBS News on Sunday. “So that’s why we’ve ramped up every way we can.”

Biden also asked American football fans to “be careful”, with health experts worried about the virus spreading at parties expected during and after the Super Bowl, the country’s biggest sporting event.

(AFP)

506 New Cases of Coronavirus Recorded in Nigeria

0

The Nigeria Centre for Disease Control has announced 506 new COVID-19 cases in 19 states and the Federal Capital Territory.

It also reported 20 deaths.

NCDC reported this via its verified Twitter handle @NCDCgov early Monday morning.

The agency said, till date, 139,748 cases of the global pandemic have been confirmed in the country.

According to the NCDC, 113,525 patients have been treated and discharged, while 1,667 deaths have been recorded in 36 states and the Federal Capital Territory so far.

It added that 24,556 active cases are currently being managed all over the country; while 1,302,410 samples have been tested so far.

The 506 new cases were reported from 20 states comprising: Ondo (90), Kwara (89), Rivers (53), Borno (45), Gombe (32), FCT (28), Imo (26), Ogun (25), Lagos (22), Kaduna (14), Kano (14), Edo (13), Osun (11), Cross River (10), Yobe (9), Ekiti (7), Kebbi (6), Nasarawa (6), Oyo (5), and Jigawa (1)

The agency noted that multi-sectoral national emergency operations centre activated at Level 3 continues to coordinate the national response activities.

“Our discharges today include 360 community recoveries in Lagos State, 138 in Osun State, 121 in Plateau State, 89 in Imo State and 38 in Kano State managed in line with guidelines,” NCDC added.

Meanwhile, the agency has recommended the following precautions to avoid infection with the COVID-19 virus:

“Avoid close contact. This means avoiding close contact within about six feet, or two meters with anyone who is sick or has symptoms. Also, keep distance between yourself and others. This is especially important if you have a higher risk of serious illness.

“Wear cloth face coverings in public places. Cloth face coverings offer extra protection in places such as the grocery store, where it is difficult to avoid close contact with others. Surgical masks may be used if available. N95 respirators should be reserved for healthcare providers.

“Practice good hygiene. Wash your hands often with soap and water for at least 20 seconds, or use an alcohol-based hand sanitiser that contains at least 60 per cent alcohol.

”Cover your mouth and nose with your elbow or a tissue when you cough or sneeze. Throw away the used tissue. Avoid touching your eyes, nose and mouth. Avoid sharing dishes, glasses, bedding and other household items if you’re sick. Clean and disinfect high-touch surfaces daily.

“Stay home from work, school and public areas if you’re sick, unless you’re going to get medical care. Avoid public transportation, taxis and ride-sharing if you’re sick.

If you have a chronic medical condition and may have a higher risk of serious illness, check with your doctor about other ways to protect yourself,” it advised.

 

UniUyo Pharmacy Faculty Gears up for PharmD Takeoff

5

– Awaits NUC verification team’s result

Barring any last minute exigency, the Faculty of Pharmacy, Federal University of Uyo will commence the PharmD curriculum, starting from the institution’s 2020/2021 academic session.

The acting Dean of the faculty, Dr Emmanuel Etim, made this disclosure during an interview with Pharmanews recently, adding that the faculty is poised for more achievements that will expedite the advancement of the Nigerian pharmaceutical industry.

Etim further revealed that the resource verification team of the National Universities Commission (NUC) visited the institution’s Faculty of Pharmacy on 7 December, 2020, for the PharmD resource verification, adding that the institution is currently awaiting the verification team’s result, which he said will hopefully be a favourable one.

Doctor Emmanuel Etim

The dean also pointed out that while the faculty is looking forward to start the PharmD programme, the departments of Pharmaceutical Microbiology and Biotechnology have been created in the faculty, stressing that this will pave way for training of experts in Quality Assurance and Quality control, as well as research into biotechnology.

He said: “There has been some innovative research in the faculty. Recently, two pharmacists from the faculty came out overall first and third place in the entire country, in a competition to harness finished product from raw materials. Given enough motivation, the faculty will achieve more.

Giving further updates on the faculty, the Etim, an associate professor of Pharmaceutical and Medicinal Chemistry, said: “Let me start with the latest development in the University of Uyo. We have a new vice-chancellor in the person of Prof. Nya Udo Ndaeyo from the Faculty of Agriculture, who was a part-time lecturer in the department of Pharmacognosy and Natural Medicine of our faculty. Before our last accreditation in 2015, the faculty had five departments but the department of Pharmaceutical Microbiology and Biotechnology has now been created.

“Recently, precisely Monday, 7, December 2020, the resource verification team from the National Universities Commission (NUC) visited our faculty for PharmD resource verification. The results of the team is awaited and hopefully our 2020/2021 admission will be for Pharm.D since I expect a positive outcome.

“The creation of the departments of Pharmaceutical Microbiology and Biotechnology is one of such efforts the Faculty of Pharmacy in the University of Uyo has put in place to advance the Nigerian Pharmaceutical Sector.

The departments will pave way for training of experts in Quality Assurance and Quality control, as well as research into biotechnology. Also the migration to Pharm. D will train pharmacists and position them well to tackle the issue of drug monitoring, and improve patient to pharmacists relationship”, the associate professor enthused.

The dean however lamented Nigeria’s dependence on importation of drugs, stating that the problem of drug importation in Nigeria will linger unless the government stops paying lip service to industrialisation.

He said: “In attempting drug manufacturing in Nigeria, you realise that everything but water is imported. However, what I am proposing is a situation where other units are up and doing. For example, the Faculty of Agriculture should cultivate and process medicinal plants for use; the Faculty of Engineering should fabricate and produce simple equipment for manufacturing; the chemical industry should produce fine chemicals which could be used for drug compounding. With these types of collaboration, we will bridge the gap in drug importation and manufacturing.”

Etim enjoined the Pharmacists Council of Nigeria (PCN) and the Pharmaceutical Society of Nigeria (PSN) to encourage the manufacturers of drugs being imported into the country to establish their factories in Nigeria, adding that the two bodies should prevail on the Nigerian government to reduce import duty for local pharmaceutical companies.

He said: “There is harmony between PCN and PSN, so they should try to convince most companies who export drugs to Nigeria to locate their factories in the country by reducing license processing fee and other incentives. PCN and PSN should try and cause government to reduce importation fee for pharmaceutical companies operating in the country and also ensure that the local drug manufacturers have access to low interest loans.

“The departments of pharmaceutics and pharmaceutical technology in faculties of pharmacy and pharmaceutical sciences should be well equipped to carry out some drug production. Learning drug production in schools will cause the students to develop a passion for industrial pharmacy.

“Just as there is waiver for the importation of some commodities, the government should give special waiver for importation of pharmaceutical raw materials and drugs. This will encourage investors in the drug industry and reduce the cost of medications. There should be serious checks at the country’s borders to reduce the influx of fake drugs.”

The dean also called on pharmacists in the country to stand by the ethics of their profession and avoid cutting corners. He also enjoined pharmacists to participate in the nation’s politics so as to get involved in the act of governance.

His words: “Nigerian pharmacists should adhere strictly to the oath of their profession. That oath which we administer during induction should be visited regularly. Pharmacists in community practice are those who fly the flag of this profession. They should be professional in practice, and avoid cutting corners.

“Our young pharmacists should know that money will come but not by registering two or more persons or selling the dignity of our profession. Most importantly, pharmacist should venture into politics so as to be involved in the general act of governance.”